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ABSTRACT 
Mitogen and specific antigen activation of bovine CD3^, 004"^, CD8^, and 
gamma delta T cell receptor"^ T cells and B lymphocytes was examined. Lymphocyte 
activation was detected by measuring increased surface expression of activation 
markers (InterIeukin-2 receptor (IL2r) and major histocompatibility complex class II 
molecules (MHC 11)). Two color flow cytometry was used to simultaneously identify 
lymphocyte subsets and detect activation marker expression. For mitogen stimulated 
lymphocyte subsets, IL2r and MHC 11 expression was compared to subset 
proliferation as measured directly by flow cytometric analysis of the fluorescent cell 
membrane stain PKH2. Stimulation by the mitogens Concanavalin A (Con A), 
phytohemagglutinin (PHA), pokeweed mitogen (PWM), and anti-CD3 monoclonal 
antibody (MAb) caused increased expression of IL2r and MHC II as well as 
proliferation of CD4'^ and CDS"^ T cells. CDS"^ T cells increased IL2r and MHC II 
expression in response to all four mitogens, and proliferated in response to Con A, 
PHA, and anti-CD3 MAb. Gamma delta T cells responded to all four mitogens with 
increased IL2r and MHC 11 expression, but only Con A and PHA caused detectable 
proliferation of gamma delta T cells. B lymphocytes generally responded to all four 
mitogens with increased IL2r and MHC n expression, but only Con A induced 
measurable B cell proliferation. Peripheral blood mononuclear cells (PBMC) of 
cattle hyperimmunized with bovine viral diarrhea virus (BVDV) were incubated in 
vitro for six days with or without live BVDV. CDS*, CD4'^, CD8*, and gamma delta 
vi 
T cells from hyperimmunized cattle became activated and increased IL2r expression 
when incubated with BVDV as compared to cells incubated without virus. 
Lymphocytes from BVDV negative control cattle did not increase IL2r expression 
when incubated in vitro with BVDV. PBMC of cattle immunized with a vaccine 
containing modified-live bovine herpesvirus 1 (BHVl) were incubated in vitro for six 
days with or without heat-inactivated BHVl. CDS"^, CD4^, and gamma delta T cells 
were activated and increased expression of IL2r when incubated with BHVl antigen 
as compared to cells incubated without virus. CDS"^ T cells of vaccinated animals did 
not increase IL2r expression when incubated with inactivated BHVl. Lymphocytes 
from non-vaccinated BHVl-negative animals did not increase IL2r expression when 
incubated with inactivated BHVl. 
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CHAPTER 1. GENERAL INTRODUCTION 
Dissertation organization 
This dissertation is composed of a general introduction, a literature review 
entitled "In vitro detection of antigen specific memory T lymphocyte subsets," three 
manuscripts, and a general summary. The manuscript entitled "Dual-color flow 
cytometric analysis of phenotype, activation marker expression, and proliferation of 
mitogen stimulated bovine lymphocyte subsets" (Chapter 3) has been submitted to 
Veterinary Immunology and Immunopathology for publication. The manuscripts 
entitled "Antigen specific in vitro activation of T lymphocyte subsets of cattle 
immunized with a modified-live bovine herpesvirus 1 vaccine" and "Antigen specific 
up-regulation of Interleukin-2 receptor on T lymphocyte subsets of cattle 
hyperimmunized with bovine viral diarrhea virus" (Chapters 4 and 5) will be 
submitted for publication. References cited in each chapter appear at the end of the 
respective chapter. The last chapter presents a summary and general conclusions of 
the research, and recommendations for future research. 
Research summaiy 
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For many important diseases, host antibody responses are relatively well 
understood, while T lymphocyte-mediated immune responses are less well 
characterized. T lymphocytes may be identified by the surface expression of CDS 
molecules. CD3'^ T cells may be divided into three subpopulations based on surface 
expression of CD4 and CDS molecules, and gamma delta T cell receptor (TCR). 
The three T cell subsets recognize antigen in different ways and are functionally 
distinct, although some overlap of function may occur. The purpose of the research 
presented in this dissertation was to develop a method to monitor the response of all 
three T cell subsets to specific viral antigens. 
Activated lymphocytes express a molecule known as Interleukin-2 receptor 
alpha (IL2r). Expression of IL2r is necessary for lymphocytes to undergo cell division 
and proliferation, which is an important aspect of the immune response to specific 
antigen. Monoclonal antibodies (MAb) have been developed that bind to bovine 
IL2r, as well as to CDS, CD4, CDS, and gamma delta TCR. It was hypothesized that 
MAb could be used to measure increased expression of IL2r on activated bovine T 
cell subsets using two-color flow cytometry. 
To validate the ability of two-color flow cytometry to measure T ceil subset 
IL2r expression, isolated bovine peripheral blood mononuclear cells (PBMC) were 
incubated with mitogens. The technique was shown to be able to measure 
differences of IL2r up-regulation between lymphocyte subsets stimulated with a given 
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mitogen, and differences in lymphocyte subset IL2r expression between various 
mitogens. Lymphocyte subset expression of IL2r was compared to mitogen induced 
proliferation, as measured by an assay that detects MAb binding to subset markers 
and the intensity of fluorescence of PKH2, a dye that stains cell membranes. 
In order to determine whether antigen specific activation of T cell subsets 
could be measured, the two-color flow cytometric technique was used to monitor T 
cell subset responses of cattle to bovine viral diarrhea virus (BVDV) infection. 
It was shown that cattle hyperimmunized with BVDV had CD3^, 004"^, CDS"^, and 
gamma delta T cells that responded to in vitro stimulation with live BVDV by up-
regulation of IL2r. T cells from BVDV negative control animals did not respond to 
BVDV. The technique was then used to monitor T cell subset responses of cattle to 
bovine herpesvirus 1 (BHVl) following vaccination. It was shown that CDS"^, CD4^, 
and gamma delta T cells, but not CDS"^ T cells, of cattle immunized with a vaccine 
containing modified-live BHVl responded to in vitro stimulation with inactivated 
BHVl by up-regulation of IL2r. T lymphocytes from unvaccinated BHVl negative 
control animals did not become activated by BHVl stimulation. The significance of 
the experimental results and considerations for possible fumre research are discussed 
in the general simimary chapter. 
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CHAPTER 2. LITERATURE REVIEW; IN VITRO DETECTION OF ANTIGEN 
SPECIFIC MEMORY T LYMPHOCYTE SUBSETS 
Introduction: the importance of memoiy lymphocytes 
Memory T lymphocytes are essential to animal health. When an animal is first 
exposed to a pathogen by vaccination or infection, there are relatively few 
lymphocytes that recognize specific antigens presented by the pathogen. The 
lymphocytes that do recognize their specific antigen become activated and proliferate, 
generating large numbers of effector cells to deal with the current infection, and 
memory cells for future use. Second exposure to the same antigen results in a faster, 
stronger, longer lasting response, the "memory response." 
Detection of antigen specific memory T cells can provide health researchers 
and clinicians with valuable information. Since different T cell subsets can have 
distinct functions (Swain, 1995), identification of the specific lymphocyte subsets that 
respond to antigen and become memory cells may be important to the basic 
understanding of disease pathogenesis and host immime responses. The ability to 
detect antigen specific memory T cell subsets may improve evaluation of existing 
vaccines, and spur the development of safer and more effective vaccines. 
Additionally, detection of antigen specific memory lymphocytes may prove valuable in 
diagnostics and epidemiolo©^. 
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What are memory lymphocytes? 
While the immunological memory response to antigen has been recognized for 
many years, the identity or existence of discrete "memory" lymphocytes has been 
debated. It is still unclear how memory T cells are generated, and whether antigen-
specific memory cells live indefinitely, or perhaps require periodic restimulation for 
continued survival (Sprent, 1995; Bell et al., 1998). Memory and naive lymphocytes 
may be distinguished by the expression of different forms of a surface molecule called 
CD45R. The terminology used to describe the variations of CD45R differs somewhat 
depending on the species, but the idea remains the same. Naive lymphocytes are 
reported to express a high molecular weight form of this molecule called CD45RA 
(in mice), while memory lymphocytes express a lower molecular weight form called 
CD45RO (Plebanski et al., 1992). However, there is evidence that the situation may 
not be that simple. 
Recent research supports two divergent models of T memory cell generation 
and maintenance. One model of 004"^ T memory cell generation postulates that 
antigen recognition by naive 004"^ T cells results in clonal expansion and 
differentiation of antigen specific lymphocytes, leading to the generation of short 
lived effector cells and two types of "memory" cells. One type of CD4^ memory cell, 
identified by the CD45RA surface antigen, exists in an activated state. CIMSRA"^ 
memory cells respond rapidly to antigen, but are relatively shon-lived and will 
disappear soon after antigen is gone. Many of these CD45RA'^ cells will revert to an 
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inactive state, identifiable by a change of the memory marker to CD45RO. 
CIMSRO"*" T cells respond to antigen slowly, like a naive lymphocyte, but may live a 
long time in ±e absence of antigen. When subsequent exposure to antigen occurs, 
the memory response is due to the expanded numbers of antigen specific CIMSRO"^ 
T cells, rather than to any enhanced ability of individual cells to respond (Richards et 
al,, 1997; Bunce et al., 1997; Bell et al,, 1998). 
Other research supports a second model of CD4'^ T memory cell generation. 
This model states that exposure of a clone of T lymphocytes to antigen generates two 
separate lineages of antigen specific T cells, similar to the simation seen in B 
lymphocytes. One lineage proliferates and differentiates into activated effector cells 
that die when specific antigen is no longer present. A separate lineage of antigen 
stimulated T cells seems not to proliferate and differentiates into long-lived, partially 
activated memory cells that respond to antigen more rapidly and aggressively than 
naive T cells. Memory cells may be distinguished from naive or effector cells by 
biochemical properties, such as differences in phosphorylation patterns of signal 
transduction molecules (Bemer et al., 1995; Gupta et al., 1997; Farber, 1998). 
Most research has been done with laboratory rodent or human 
lymphocytes. The situation is even less clear for CDS'" memory T cells, and for 
lymphocytes of other species. There is evidence that supports the theory that 
memory 008"^ T cells may persist in the absence of antigen or other immune cells, 
but may require periodic stimulation by cytokines or contaa from some type of 
stromal cell. Other research indicates that recurring exposure to persistent antigen is 
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necessary for CDS"^ memory cell maintenance (Arvin et al., 1991; Sprent, 1995; Di 
Rosa et al., 1996). It is reported that bovine CD4^ memory T cells maintain 
expression of CD45R0, while CD8^ memory T cells initially express CD45RO, but 
soon down-regulate CD45RO expression (Bembridge et al., 1995). 
Applications for detection of antigen speciflc memoiy lymphocytes 
In basic research, detection of expanded clones of antigen specific memory 
lymphocytes may lead to a greater understanding of pathogenesis and immune 
responses to many diseases. Techniques to study generalized T lymphocyte responses 
to antigen have been available for many years. For example, lymphocyte 
blastogenesis tests measure isolated lymphocyte DNA synthesis (proliferation) when 
exposed to antigen or mitogens in vitro. However, this assay yields no information 
regarding which of the functionally distinct lymphocyte subsets recognizes and 
responds to specific antigen. Several newer techniques are able to identify 
lymphocyte subsets and detect cell activation or functional activities. For example, 
flow cytometry can be used to identify lymphocyte subsets and simultaneously detect 
various measures of activation. Antigen-induced cytokine production can give clues 
regarding the functional activities of the lymphocyte subsets that are activated by 
antigen. Such techniques have been used to detect antigen specific lymphocytes and 
can yield much useful information about disease pathogenesis and immime responses 
(Clough et al., 1995). 
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Deteaion of antigen specific T cells should be very useful in the field of 
vaccinology as well. Antibody responses to vaccines are well studied. However, T 
cell mediated immune responses (CMI) to many vaccines are poorly characterized, 
despite the fact that CMI is an important protective response for many diseases, 
especially intracellular bacteria, viruses, fungi, and protozoal diseases. The ability to 
detect and quantify CMI responses and activation of specific lymphocyte subsets 
would provide ways to identify protective T cell epitopes, evaluate vaccine efficacy, 
and aid in the development of novel vaccine technology (Herr et al., 1996; Hackett, 
1997). Many new vaccine techniques are being developed to specifically stimulate 
cell mediated immune responses (Bona et al., 1998). To fully exploit such new 
developments, T lymphocyte subset responses to diseases must be well characterized, 
and specific T cell subset responses to vaccination must be measurable. 
Vaccine technology has advanced to the point of being able to stimulate 
specific types of immune cells to achieve the optimal protective response. Use of the 
appropriate adjuvant can determine which lymphocyte subsets are activated (Neuzil 
et al., 1997; Baldridge et al., 1997; Benne et al., 1997; Krivorutchenko et al., 1997). 
Antigens may be bound to synthetic particulate carriers or immune-stimulating 
complexes (ISCOMS) to enhance presentation to T cells (Prieur et al., 1996; 
Challacombe et al., 1997; Sjolander et al., 1997; Men et al., 1997). Vaccines can be 
designed using native or synthetic antigens, or combinations, so that antigen is 
presented to a given type of lymphocyte or antigen presenting cell (APC) or both 
(Condon et al., 1996; Zhang et al., 1997; Nakamura et al., 1997; Yang et al., 1997; del 
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Guercio et al., 1997). When DNA vaccines are administered by different routes, 
antigen may be presented and processed by different immune ceils to induce different 
immune responses (Yokoyama et al., 1997; Prayaga et al., 1997; Barry et al., 1997). 
Other genetic immunization techniques include fusing an antigenic protein to a 
molecular adjuvant to increase stimulation of APCs (Kowanko et al., 1991), and using 
DNA vaccines that code for production of antigenic peptides together with genes for 
the production of cytokines to guide the immune response (Maecker et al., 1997; 
Barry et al., 1997; Lewis et al., 1997; Prayaga et al., 1997). Immune responses could 
be modulated by changing the intracellular location of an antigen produced by DNA 
vaccine by adding signal sequences or trans-membrane domains (Ertl et al., 1996). 
Such techniques may lead to vaccines that stimulate the most appropriate cell types 
to maximize protective immune responses while eliminating unnecessary or harmful 
antigens (Bona et al., 1998). 
For diseases under eradication programs, marker vaccines have been 
developed that allow serological differentiation of infected animals from vaccinates. 
Such vaccines have been developed for swine pseudorabies and bovine herpesvirus 1 
(Stegeman et al., 1994; Bosch et al., 1998). These vaccines are engineered to contain 
protective epitopes, but lack some antibody producing antigens found in wild type 
viruses. For diseases in which CMI is more protective than humoral immunity, it may 
be possible to design a vaccine that induces memory T cells to a very restricted range 
of epitopes, or perhaps produces CMI without antibody. In vitro detection of antigen 
specific T cells would allow differentiation of vaccinates and infected animals. 
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In the field of diagnostics, in vitro detection of antigen-specific memory cells 
could prove a valuable addition to serology and delayed-type hypersensitivity (DTH) 
skin testing. Diagnosis of some diseases, bovine paratuberculosis for example, has 
been a difficult or lengthy process prone to false negative results (Onet, 1997). An in 
vitro assay to detect memory T cells specific for paratuberculosis has recently been 
described (Stabel, 1996), which should improve the speed and accuracy of diagnosis 
of this disease. For some diseases, antibody titers decline below detectable levels 
over time, or little antibody is produced. Expanded clones of memory T cells may be 
detectable for longer times than antibody, or in situations where little or no antibody 
is produced (Di Rosa et al., 1996), improving disease surveillance. Antibody in serum 
of young animals may be due to passively acquired maternal antibody or active 
response to disease. Detection of antigen specific memory cells could differentiate 
between the two options. The presence of maternal antibody may prevent neonates 
from seroconverting when infected or vaccinated (Bradshaw et al., 1996; Ellis et al., 
1996); detection of antigen specific memory cells may be a more reliable way to 
detect exposure of neonates to some agents. 
T lymphoQie subsets 
Two functionally distinct subsets of T lymphocytes are described on the basis 
of surface expression of accessory molecules CD4 or CDS. CD4'^ T cells are 
generally regarded as cytokine producing or "helper" cells, while CDS"^ T cells are 
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cytotoxic cells (McKeever, 1994), but both types of cells may be capable of either 
activity under some conditions (Arvin et al., 1991; Choi et al., 1994; Herr et al., 
1996). Most CD4^ and CDS"^ T lymphocytes possess the alpha beta T cell antigen 
receptor (TCR). Alpha beta T lymphocytes cannot recognize native antigen; they 
respond only to peptide antigens that have been processed by antigen presenting cells 
(APC) and presented on the surface of APCs bound by major histocompatibility 
molecules (MHC). 
Gamma delta T lymphocytes possess a T cell receptor that consists of two 
chains analogous to, but distinct from, that of alpha beta T cells. Gamma delta T 
cells are commonly found at dermal and mucosal surfaces. Gamma delta T cells are 
a minor population in peripheral blood of most species, but are prominent in the 
blood of ruminants (Parker et al., 1990; Hein et al., 1991). Gamma delta T cells can 
secrete cytokines that modulate immune responses and attract inflammatory cells to 
sites of infection, and may possess cytolytic activity (Lang et al., 1995; Boismenu et 
al., 1996). The antigens they recognize and how they recognize them is poorly 
understood. At least some gamma delta T cells recognize phosphorylated non-
peptide antigens that are not processed by antigen presenting cells or presented by 
classical MHC molecules (Morita et al., 1995). The phosphoantigens recognized by 
such gamma delta T cells are components of the cell wall of many bacteria. Gamma 
delta T cells seem to be particularly important in responses to mycobacterial 
infections, but have been reported to respond to neoplastic and virus-infected cells as 
well (Fisch et al., 1990; Bukowski et al., 1994). 
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It has been suggested that gamma delta T lymphocytes are intermediate 
between non-specific defense mechanisms, such as neutrophils and macrophages, and 
specific immunity mediated by alpha beta T cells. They recognize antigen more 
specifically and respond more slowly than neutrophils and macrophages; they 
recognize antigen less specifically than alpha beta T lymphocytes and respond more 
rapidly (Kaufmann, 1996). Gamma delta T cells may be of particular importance 
during first exposure to an organism, when only 0.1 - 0.0001% of alpha beta T cells 
respond to a specific peptide-MHC complex, while 1-8% of gamma delta cells 
respond to phosphoantigens. They may be of less importance in secondary exposure 
when antigen specific alpha beta T cell clones have expanded (Poccia et al., 1997). 
Methods of in vitro detection of T ceil activation 
Humoral responses to many diseases have been extensively studied. However, 
the ability to study CMI has developed more slowly. CMI may be demonstrated by 
detecting the presence of expanded clones of T lymphocytes, i.e. memory cells, that 
recognize pathogen-specific antigens (Roth, 1993). Several parameters have been 
used in vitro to differentiate mitogen- and antigen-stimulated lymphocytes from 
unstimulated resting lymphocytes. Activated cells may be identified by changes in 
metabolism or expression of surface molecules. Cytokine production, cytotoxicity, or 
other functional assays may be used to identify stimulated lymphocytes. Proliferation 
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of lymphocytes is often used as a way to demonstrate activation of lymphocytes by 
mitogens and antigens (Clough et al., 1995). 
Some assays, such as lymphocyte blastogenesis, can detect T cell responses, but 
give no information regarding which of the functionally different T cell subsets are 
responding to antigen. In an attempt to determine the roles of different subsets, 
isolated lymphocytes may be depleted or enriched of T cell subsets for these assays 
(Chiodini et al., 1992; Lutje et al., 1992). However, the interactions of different 
subsets cannot be studied in separated populations of lymphocytes. 
Detecting activation of memory T lymphocytes 
Metabolic changes may be detected in lymphocytes within minutes following 
stimulation. Fluorescent probes allow rapid measurement of several different types 
of metabolic changes that occur early in activation. Intracellular calcium flux 
(Rabinovitch et al., 1986; June et al., 1986; Gelfand et al., 1988b), cytoplasmic pH 
changes (Rogers et al., 1983; Gelfand et al., 1988a), changes in oxidative metabolism 
(Shapiro, 1995b), and altered membrane potential (Shapiro et al., 1979) have been 
used to observe early lymphocyte activation. 
Lymphocyte activation results in the expression of cell surface molecules not 
present on resting cells. Some surface markers of activation are expressed within a 
few hours of stimulation, others do not appear for days. Some surface molecules that 
have been used to detect lymphocyte activation, in order of their appearance 
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following stimulation, include CD69 (Lopez-Cabrera et al., 1993), CD98 (Friedman et 
al., 1994), CD25 (imerleukin-2 receptor), insulin receptor (Cebrian et al., 1988; Biselli 
et al., 1992), CD21 (transferrin receptor) (Suomalainen, 1986), and MHC class 11 
molecules (Uchiyama et al., 1981; Haynes et al., 1981; Shapiro, 1995b). 
Of these activation markers, interleukin-2 receptor (IL2r) may be the most 
relevant physiologically. Soon after antigen recognition, lymphocytes begin to express 
high affinity IL2r on their surface. Activated T cells also secrete interleukin-2. 
Binding of IL-2 to its receptor is a powerful stimulus to induce cell division. In an 
immune response, only lymphocytes that have recognized specific antigen express 
high levels of IL2r and bind enough IL-2 to undergo proliferation (Miyawaki et al., 
1982; Smith, 1988; Minami et al., 1993; Abbas et al., 1994). IL2r expression requires 
new protein synthesis, but occurs before measurable DNA synthesis or cell division 
(Uchiyama et al., 1981; Rubin et al., 1985; Redelman et al., 1986). Cells expressing 
IL2r at 12-24 hours post-stimulation correlate well with cells synthesizing DNA 120 
hours after stimulation; it appears that cells bearing IL2r early during activation are 
the T cells which proliferate later (Shapiro, 1995b). Expression of IL2r may be 
induced by specific antigen, mitogens, or by some T cell specific MAb (Cantrell et al., 
1984; Smith, 1988). 
Expression of IL2r is an early indication of lymphocyte activation and 
represents the potential to proliferate. However, lymphocytes may express IL2r 
without dividing (Rubin et al., 1985). There is evidence that some antigens may 
activate lymphocytes enough to increase IL2r expression, but the cells become anergic 
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or unresponsive; these anergic lymphocytes expressing IL2r may even act as 
suppressor cells by consuming locally produced IL-2 and preventing potentially 
responsive lymphocytes from receiving adequate stimulation to proliferate (Lombard! 
et al., 1994). 
Expression of activation molecules is commonly studied using fluorescent 
immunohistochemistry and flow cytometry. A wide selection of monoclonal 
antibodies and other reagents is available for use with human and rodent 
lymphocytes. There are relatively fewer antibodies available for studying leukocytes 
from species of veterinary importance, but the selection of such products is 
expanding, especially for dogs (Cobbold et al., 1994), ruminants (Naessens et al., 
1996), swine (Saalmuller et al., 1996), and horses (Lunn et al., 1996). For example, 
MAb are available to differentiate bovine T lymphocyte subsets CDS"^ (Davis et al., 
1993), CD4'^ and CD8* (Larsen et al., 1990), gamma delta T cells (Davis et al., 
1996a), and B cells (Sopp, 1996), as well as activation markers such as IL2r (CD25) 
(Naessens et al., 1992; Davis et al., 1996b) and MHC II (Davis et al., 1987). 
Monoclonal antibodies have been used in dual color flow cytometry to determine 
which specific lymphocyte subsets upregulate expression of activation molecules in 
response to in vitro culture with antigen or mitogen in several animal species 
including swine (Dillender et al., 1993), sheep (Bujdoso et al., 1993; Begara et al., 
1995), cattle (Stone et al., 1995; Ferens et al., 1998), and deer (Hesketh et al., 1993), 
as well as humans (Rubin et al., 1985; Prince et al., 1986; Ito et al., 1992; Gaines et 
al., 1996). 
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Proliferation assess for detection of memory T cells 
Another method of determining lymphocyte activation is by measuring 
synthesis of DNA. DNA synthesis begins about 30-36 hours following stimulation 
(Shapiro, 1995b). Since the 1960's, DNA synthesis has been measured by the 
incorporation of tritiated thymidine into newly synthesized DNA, called lymphocyte 
blastogenesis or lymphocyte transformation. This technique has been used to detect 
mitogen and antigen stimulated lymphocytes of many species (Chiodini et al., 1992; 
Lutje et al., 1992; Brown et al., 1993; Baca-Estrada et al., 1996; DeBey et al., 1996). 
While blastogenesis provides valuable information, it reveals nothing concerning 
which lymphocyte subsets are responding or their effector function (Clough et al., 
1995). Specific subsets may be enriched or depleted and the results compared to 
those obtained using the total lymphocyte population, thereby giving clues as to which 
subsets are proliferating. 
Synthesis of RNA and DNA can be measured using a number of different 
substances that bind to or incorporate into nucleic acids. Increased amounts of 
cellular RNA or DNA indicate that lymphocytes have been activated by mitogen or 
antigen. Many of these nucleic acid markers are fluorescent and may be detected by 
flow qtometry, which allows the simultaneous identification of lymphotyte subsets 
using MAb (Shapiro, 1995b). Acridine orange (Braunstein et al., 1975; 
Dar^Tikiewicz et al., 1976; Traganos et al., 1977) and pyronin Y (Redelman et al., 
1986) have been used to quantitate RNA, while prodidium iodide (Rosat et al., 
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1994), bromodeoxyuridine (Gaines et al,, 1996), Hoechst DNA-binding dyes (Blaheta 
et al., 1991), and DNA-binding antibiotics (Costa et al., 1975; Shenker et al., 1995) 
have been used to quantitate DNA. Monoclonal antibody against proliferating cell 
nuclear antigen (PCNA) has also been used to measure increased lymphocyte DNA 
content following stimulation (Hesketh et al., 1993). Fluorescent markers of nucleic 
acid synthesis can detect smaller numbers of activated cells at an earlier time than 
tritiated thymidine incorporation (Shapiro, 1995b). Many of these nucleic acid 
markers have been used to detect antigen specific and mitogen activation of 
lymphocytes (Le Moal et al., 1992; Hesketh et al., 1993; Gaines et al., 1996) 
Proliferation of lymphocytes has been measured using fluorescent dyes that 
incorporate into cell membranes. Derivatives of cyanine dyes (e.g. 
dioctadecylindocarbocyanine) have been used, and the recently introduced series of 
PKH cell tracking dyes (Sigma) have been used for this purpose (Weston et al., 1990; 
Ragnarson et al., 1992; Shapiro, 1995a). Lymphocyte membranes may be stained 
with dyes prior to incubation with antigen or other stimulants. Following incubation 
with stimulants, lymphocytes may be labeled with MAb against subset markers to 
identify which subsets are responding to stimulation by proliferating. When analyzed 
by flow (ytometry, proliferating cells contain progressively less dye with each new 
generation, giving information regarding what percentage of cells of a given 
lymphocyte subset are proliferating and to what extent they have divided (Horan et 
al., 1990; Shapiro, 1995a). 
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Cytokine production as a method of detecting memory T lymphocytes 
Production of cytokines may be used to detect activated memory lymphocytes. 
There are several methods available to measure the production of cytokines, such as 
bioassays using cytokine-dependent cell lines, and direct measurement of cytokines 
using ELISA techniques. Some bioassays and ELISA reagents are species specific 
and the availability of reagents specific for species of veterinary interest has been 
limited, but is improving (Clough et al., 1995). A number of cytokine-dependent cell 
lines are available to perform bioassays to measure cytokine production from 
stimulated lymphocytes, especially for human and rodent cytokines. Bioassays have 
been used to detect antigen specific production of IL-2, IL4, IL-5, and interferon-
gamma (INF-gamma) (Kelso et al., 1995; Prigione et al., 1995). Bioassays of 
lymphocyte production of INF-gamma, tumor necrosis factor (TNF), and IL-2 have 
been used to detect antigen specific memory T cells in cattle (Brown et al., 1993). 
ELISA technology is available to measure several cytokines. Antigen specific 
memory T cell production of IFN-gamma, IL-2, IL-4, IL-5, and IL-12 have been 
demonstrated in human (Prigione et al., 1995) and mouse lymphocytes (Falchetti et 
al., 1995; Cooper et al., 1995). ELISA detection of IFN-gamma production has been 
used to demonstrate antigen specific memory T cells in cattle infected with 
Mycobacterium bovis (Kee et al., 1997), Mycobacterium paratuberculosis (Stabel, 1996), 
and Pasteurella haemolytica (DeBey et al., 1996). 
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ELISPOT is a type of ELISA that can quantitate the number of cells that are 
producing a certain cytokine. Antigen specific cytokine secretion of INF-gamma, IL-
2, IL-4, IL-5, TNF has been detected by ELISPOT primarily in laboratory rodents 
(ElGhazali et al., 1993; Xu-Amano et al., 1994; Murphy et al., 1997; Culshaw et al., 
1997), but the technique has been used to detect antigen specific IFN-gamma 
production by lymphocytes of swine (Husmann et al., 1996). 
Activation of T cells may be analyzed by demonstrating intracellular cytokine 
mRNA- Northern blotting (Brown et al., 1993) and reverse transcription-polymerase 
chain reaction (RT-PCR) can be used to identify and quantitate cytokine mRNA in 
lymphocytes (Keiso et al., 1995; Prigione et al., 1995). Reagents and techniques for 
RT-PCR detection of mRNA for IL-2, IL-4, IL-6, EL-10, EL-12, interferon gamma, 
and tumor necrosis factor have recently been described for use in cattle, cats, dogs, 
horses (Rottman et al., 1996), swine (Rottman et al., 1996; Dozois et al., 1997), and 
sheep (Egan et al., 1996). Antigen specific memory cell cytokine mRNA has been 
detected in lymphocytes from cattle infeaed with Mycobacterium bovis (Kee et al., 
1997) and Babesia bovis (Brown et al., 1993). Monoclonal antibody against IL-2 and 
IL-4 may be used to detect intracellular cytokine molecules. These antibodies have 
been used in conjunction with stirface subset markers to identify lymphocyte subsets 
and production of specific cytokines in mice (Falchetti et al., 1995). 
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Cytotoxicity assays for detection of memory T cells 
Ototoxicity assays measure the ability of cytotoxic T lymphocytes (CTL) to 
destroy target cells. Cytotoxic T cells are typically of the CDS"^ subset, but CD4'^ and 
gamma delta T lymphocytes may also possess cytotoxic properties (Arvin et al., 1991; 
Choi et al., 1994; Lang et al., 1995). Target cells are labelled with a substance that is 
taken up by the cells and maintained intracellularly. When labelled target cells are 
incubated with potential CTLs, release of marker substance into the medium 
indicates target cell lysis. The most commonly used marker for CTL assays is 
radioactive chromium, but tritium (Matzinger, 1991) and non-radioactive Europium 
have also been used (Blomberg et al., 1986). Alternatively, the release of 
lymphocyte-specific substances, such as granzyme, may be used to demonstrate that 
CTLs have recognized and responded to target cells (Baetz et al., 1995). 
Since CDS'*" T cells recognize antigen only when it is presented on "self MHC 
class I molecules, target cells for CTL assays must be histocompatibility matched with 
the CTLs to be tested. Histocompatibility matching means that cytotoxicity assays are 
relatively simple with the genetically identical strains of laboratory rodents that are 
available (Pemberton et al., 1987), but presents the challenge of haplotype matching 
or establishing and culturing autologous target cells when testing outbred species for 
CTLs. Nevertheless, antigen specific CTL activity has been demonstrated in several 
species of veterinary importance, including cattle (Denis et al., 1993; Gaddum et al.. 
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1996), sheep (Woldehiwet et al., 1994), swine (Pauly et al., 1995), poultry (Thacker et 
al., 1995), horses (McGuire et al., 1997), and cats (Tellier et al., 1997). 
Summaiy 
In vitro detection of antigen specific memory T lymphocytes could provide 
information valuable to basic understanding of host-pathogen interactions, vaccine 
development and evaluation, and disease diagnosis. Memory T cells may be detected 
by increased expression of activation markers, proliferation, cytokine production, and 
lysis of target cells. Some measures of lymphocyte activation may represent 
incomplete activation that does not result in a functional response to antigen. It may 
be that proliferation assays most accurately determine which immune cells are 
responding to antigen in a protective manner. Perhaps some combination of surface 
molecule expression, proliferation, and cytokine secretion will provide the most 
accurate information regarding what cells are activated and how those cells are 
responding functionally to specific antigen. 
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CHAPTER 3. DUAL-COLOR FLOW CYTOMETRIC ANALYSIS OF PHENOTYPE, 
ACTIVATION MARKER EXPRESSION, AND PROLIFERATION OF MITOGEN 
STIMULATED BOVINE LYMPHOCYTE SUBSETS 
A paper submitted to Veterinary Immunology and Immunopathology 
Mark J. Quade and James A. Roth 
Abstract 
Bovine peripheral blood mononuclear cells were cultured in vitro for three 
days with the mitogens Concanavalin A (Con A), pokeweed mitogen (PWM), 
phytohemagglutinin (PHA), and anti-CD3 monoclonal antibody (MAb). Activation of 
T lymphocyte subsets (CD3^, €04"^, CD8^, and gamma delta T cell receptor"^ 
(TCR)) and of B lymphocytes was measured by blastogenesis and by two-color flow 
cytometric analysis of subset expression of IL-2 receptor (CD25) and MHC class U. 
Proliferation of lymphocyte subsets was directly measured by two-color flow 
cytometric analysis of fluorescence intensity of PKH2, a fluorescent dye that stably 
incorporates into cell membranes. CDS"^, 004"^, and CDS"^ T cell subsets were 
activated by all the stimulants to increase expression of IL2r and MHC n and to 
proliferate, except that PWM did not cause measurable CDS* cell proliferation. 
Gamma delta T cells responded to all four stimulants with increased IL2r and MHC 
n expression. Con A and PHA caused measurable proliferation of gamma delta T 
cells, but PWM and anti-CD3 MAb did not. B cells generally responded to the 
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stimulants with increased IL2r and MHC II expression. B cells proliferated when 
incubated with Con A, but did not measurably proliferate in response to PWM, PHA, 
or anti-CD3 MAb. 
Keywords bovine, mitogens, T cell subsets, lymphocyte proliferation, activation 
Introduction 
Mitogens have been used to activate lymphocytes and to induce them to 
proliferate in many species, including cattle. To study the effects of mitogens on 
different lymphocyte subsets, lymphocyte blastogenesis has been measured following 
depletion or enrichment of subsets from the total population of lymphocytes. It was 
concluded that for bovine lymphocytes, concanavalin A (Con A) and 
phytohemagglutinin (PHA) stimulated T lymphocytes, while pokeweed mitogen 
(PWM) stimulated both T and B cells (Schultz, 1981; Usinger et al., 1981; Luqe et 
al., 1992). Early work on the effects of mitogens on lymphocytes did not examine the 
effects on gamma delta T cells, which have been shown to be a major subpopulation 
of circulating lymphocytes in cattle (Hein et al., 1991). In vivo depletion of bovine 
gamma delta T cells has been shown to increase blastogenesis due to PWM (Howard 
et al., 1989), and there is evidence that the in vitro proliferative responses of gamma 
delta T cells may be slower than other T lymphocyte subsets when stimulated by 
PWM (Franklin et al., 1994). 
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The availability of monoclonal antibodies (MAb) for cattle lymphocyte subset 
markers, along with the use of flow cytometry, has enabled researchers to more 
directly study the effects of mitogens on bovine lymphocyte subpopulations. 
Monoclonal antibodies have been produced that define bovine T lymphocyte antigens 
CD3 (Davis et al., 1993), CD4 (Bensaid et al., 1991), CDS (Larsen et al., 1990), and 
gamma delta T cell receptor (TCR) (Davis et al., 1996a), as well as B cell markers 
such as CD21 (Mukwedeya et al., 1993; Sopp, 1996). Single color flow cytometry has 
been used to study mitogen induced changes in percentages of lymphocyte subsets 
(Hurley et al., 1994; Franklin et al., 1994) and surface expression of lymphocyte 
activation markers, such as Interleukin-2 receptora (IL2r) (Miyawaki et al., 1982; 
Prince et al., 1986) and major hisotcompatibility complex class II (MHC II) (Davis et 
al., 1987). Using two-color flow cytometry, it is possible to identify the specific 
subsets of lymphocytes of humans (Uchiyama et al., 1981; Mach et al., 1996), cattle 
(Hurley et al., 1994; Davis et al., 1996b; Ferens et al., 1998; Isaacson et al., 1998) and 
other species (Le Moal et al., 1992; Dillender et al., 1993) that increase expression of 
IL2r and MHC n when activated by mitogens, antigens, and superantigens. 
Lymphocyte activation may lead to proliferation. Proliferation may be 
measured using PKH2 fluorescent cell tracking dye (Sigma), which incorporates into 
the membrane of living cells. It has been shown that PKH2 dye does not interfere 
with lymphocyte proliferation (Samlowski et al., 1991). Labeled lymphocytes are 
cultured in vitro with stimulants, and proliferating cells may be identified by a 
reduction in fluorescence intensity relative to cells that have not divided (Horan et 
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al., 1990). The phenotype of PKH2-labeled proliferating lymphocytes can be 
identified using lymphocyte subset specific MAb and dual-color flow cytometry 
(Shapiro, 1995b). 
In this study, bovine lymphocyte subset responses to four commonly used 
stimulants were compared using three different methods. Isolated bovine peripheral 
blood mononuclear cells (PBMC) were cultured with Con A, PHA, PWM, and anti-
CD3 MAb for three days. Activation of lymphocytes was compared using lymphocyte 
blastogenesis, two-color flow cytometry to measure lymphocyte subset expression of 
IL2r and MHC 11, and two-color flow cytometric analysis of lymphocyte subset 
proliferation. 
Materials and methods 
Reagents 
Mitogens were used at final concentrations determined to be optimal for 
lymphocyte blastogenesis (incorporation of ^H-thymidtne) in our laboratory (Con A 
2.5Mg/ml, PWM 1:500, and PHA O.S/xg/ml) (Sigma). Culture medium (RPMI+) 
consisted of RPMI 1640 (Celox) containing 10% heat inactivated fetal bovine serum 
negative for bovine viral diarrhea virus (BVDV) and BVDV antibody (Hy-clone) and 
0.5% cell culture penicillin/streptomycin (Sigma). The PKH2 fluorescent membrane 
dye kit was purchased from Sigma. 
Monoclonal antibodies 
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Mouse MAb that bind to bovine antigens were purchased from VMRD Inc. 
(Pullman, WA) and are shown in table 1. Affinity purified goat anti-mouse isotype 
specific secondary antibodies were purchased from Caltag (Burlingame, CA): 
phycoerythrin (PE) labeled anti-IgG2a (M32204), fluorescein isothiocyanate (FITC) 
labeled anti-IgGl (M32101), FTTC-labeled anti-IgG2b (M32501), and FTTC-labeled 
F(ab)2 anti-IgM (M31601). Mouse MAb of irrelevant specificity used as isotype 
controls were purchased from Caltag; IgGl (MGIOO), IgG2a (MG2a00), IgG2b 
(MG2b00) and IgM (MGMOO). 
Isolation and culture of peripheral blood mononuclear cells 
Peripheral blood mononuclear cells were isolated from healthy 3-6 month old 
Holstein steers (n=5-8) using a previously described method (DeBey et al., 1996). 
Briefly, citrated blood was centrifuged, the buJ^ coat was collected, and 
contaminating erythrocytes lysed by hypotonic flash lysis. PBMC were washed twice 
in Hanks balanced salt solution without Ca"^"^ and Mg"^"^ (HBSS), and resuspended at 
2 X 10®/ml in 5ml RPMI+ in 6-well tissue culture plates. Isolated cells were >95% 
viable by trypan blue exclusion. 
Control wells contained medium and cells only, while wells with mitogen 
stimulated cells contained Con A, PHA, PWM, or anti-CD3 MAb. All treatments 
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were set up in duplicate. Con A and PWM were tested simultaneously, PHA and 
anti-CD3 were tested on separate occasions. For use as a stimulant, anti-CD3 MAb 
(MMIA, 0.5ml at lOug/ml HBSS) was adhered to plates by incubating overnight at 
4°C. Unbound anti-CD3 was removed by rinsing wells twice with HBSS. Plates 
containing medium, cells, and stimulants were incubated in humidified 5% CO, 
atmosphere at 39°C for three days. 
For the proliferation assay, isolated PBMC were labeled according to the 
manufacturer's procedure with green-fluorescent PKH2 before being placed in 
culture. PBMC (2 x 10') were suspended in 1 ml proprietary diluent (Sigma), and 
incubated with an equal volume of PKH2 dye (4 x lO'^M) in diluent for 6-7 minutes. 
Fetal bovine serum (2ml) was added to stop the reaction, and the cells were washed 
three times with RPMI 1640. One third of each sample was immediately labeled 
with MAb against CD3, CD4, CDS, CD21, or gamma delta T cell receptor (TCR) 
and analyzed flow cytometrically. The remaining PKH2 labeled PBMC from each 
animal were divided equally and 4 x 10^ cells were resuspended in 5ml RPMI+ in 6 
well culture plates and incubated (39°C, 5% COj) with or without stimulants as 
described above. 
Preparation of cultured PBMC for flow cytometric analysis 
After three days of incubation, plates were chilled on ice. Media and non­
adherent cells were collected by gentle pipetting, followed by a gentle rinse with cold 
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HBSS. Wells were then treated with 1 ml cold trypsin/EDTA for 3-4 minutes, 
followed by vigorous rinsing with cold HBSS. Cells recovered wi± media and rinses 
were pooled, and cells from duplicate wells were pooled for further processing. A 
small percentage of cells remained adhered and could not be recovered by this 
method. Recovered cells were washed twice in cold HBSS, then washed and 
resuspended in cold phosphate buffered saline containing 0.5% bovine serum albumin 
and 0.1% NaNj (PBS+ +). Cells (1 x 10^) were placed in replicate wells of 96-well u-
bottom microtiter plates. All cells were incubated with two primary antibodies: a 
lymphocyte subset specific antibody and antibody against IL2r or MHC n. All 
primary MAb were diluted to lOMg/ml PBS + + , except anti-CD4 was 20Mg/ml. 
Duplicate wells received 25/iI of primary MAb specific for either CDS (MMIA), CD4 
(CACT138A), CD8a (CACT80C), gamma delta TCR (GB21A), or B cells 
(BAQ15A). Half of the wells containing each subset specific MAb then received 
25mI anti-IL2r MAb (CACT108A) and half received 25/il anti-MHC n MAb 
(TH14A). Isotype control wells containing MAb of irrelevant specificity were run for 
mitogen treated and untreated cells fi-om each animal. All isotype control wells 
contained 25/11 of IgG2a isotype (control for anti-IL2r and -MHC II), and either 25/xl 
IgGl isotype (control for anti-CD3, -CD4, -CDS, -CD21) or 25m1 IgG2b isotype 
(control for anti-gamma delta TCR), each diluted lOMg/ml PBS+ +. 
Cells and primary antibodies were incubated at 4°C for 30 minutes. Cells 
were then washed four times in PBS+ + and resuspended in PBS-i- + containing 
fluorescently labeled secondary antibody. All wells received 25mI of PE-labeled anti-
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IgG2a to label IL2r and MHC 11 MAb, and 25^1 FITC-labeled secondary antibody 
against the appropriate isotype of subset specific MAb. All secondary antibodies 
were diluted to lOjug/ml PBS + +. Cells and secondary antibodies were incubated for 
30 minutes at 4°C in the dark. Cells were washed five times with HBSS, then fixed in 
1% paraformaldehyde in PBS for flow cytometric analysis. 
When anti-CD3 MAb (MMIA) was used as a stimulant, the procedure was the 
same as above, except the following IgM isotype primary antibodies were used 
(VMRD): CD4 (GC50A1), CD8a (BAQlllA), gamma delta TCR (CACT61A), B 
cell (BAQ44A). Fluorescently labeled secondary antibody was FITC-labeled anti-IgM 
(M31601) and isotype control antibody was IgM (MGMOO) (Caltag). 
Fluorescence of lymphocyte subsets and IL2r or MHC 11 was analyzed using a 
Coulter XL-MCL flow cytometer equipped with standard software. Lymphocytes 
were discriminated by forward and side light scatter parameters. Ten thousand cells 
from each sample were analyzed. Quad-stat gates were set using unstimulated 
control cells stained with isotype control primary MAb and isotype specific FITC- and 
PE-labeled secondary antibodies. 
For PKH2 flow cytometric analysis, labeled cells were cultured and harvested 
as above. Cells were incubated for 15 minutes at 25°C with MAb against CD3 
(MMIA), CD4 (GC50A1), CD8a (CACT80C), gamma delta TCR (CACT61A), and 
B cells (BAQ44A), all at T^g/ml final concentration. Cells were washed and 
incubated with isotype-specific PE-labeled secondary antibody for 15 minutes at 25°C. 
Cells were washed to remove unbound antibody and analyzed without fixation. 
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Proliferation of each lymphocyte subset was analyzed on a FACScan (Becton 
Dickinson) with argon laser excitation at 488nm. PKH2 fluorescence was collected in 
the FLl channel (515-545nm), secondary antibody PE fluorescence was collected in 
the FL2 channel (564-606nm). Five thousand cells from each sample were analyzed. 
Cells positive for a given phenotype marker were selectively gated, and PKH2 
fluorescence was analyzed using Proliferation Wizard software (Verity Software 
House, Topsham, ME). The fluorescence intensity of PKH2 labeled cells that were 
analyzed on day 0 was used to establish the fluorescence intensity of the undivided or 
parent generation of cultured cells. 
Lymphocyte blastogenesis 
Lymphocyte blastogenesis was performed as previously described (Roth et al., 
1982). Briefly, isolated PBMC were resuspended at 1 x 10^/ml culture medium. Two 
hundred n\ of cell suspension was placed in wells of flat-bottom 96-well microliter 
plates. Treatments consisted of no mitogen added (background), or 25jul of Con A, 
PWM, or PHA at the same concentrations used for the other assays. Anti-CD3 
MAb, lOOjLil at 10/ig/ml, was adhered to wells as described. All treatments were set 
up in triplicate. Plates were incubated in humidified 5% COj atmosphere at 39°C. 
Cells were pulsed with l/xCi ^H-thymidine per well after 2 days of incubation, 
harvested 18 hours later, and counts per minute (cpm) of radioactivity measured. 
Data Analysis 
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Blastogenesis results are reported as mean counts per minute (q)m) of 
radioactivity. Stimulation indexes were calculated using this equation: 
cpm of mitogen stimulated cells 
cpm of same animals' unstimulated control cells 
For lymphocyte subset expression of activation markers, the percentage of cells 
expressing each phenotype marker that were positive for either IL2r or MHC n was 
calculated. Mean fluorescence intensity of IL2r or MHC 11 expression 
(phycoerythrin), which correlates to the density of surface molecule expression 
(Shapiro, 1995a), of double positive cells was determined. IL2r or MHC 11 
expression indexes were calculated for each lymphocyte subset using the following 
equation: 
(% stimulated cells in subset positive for IL2r1fniean PE fluorescence intensity of stimulated cellsl 
(% same animal control cells positive for IL2r)(mean PE fluorescence intensity of control cells) 
For PKH2 stained lymphocytes, for each subset the percentage of cells in the 
parent generation and generations 2-6 was determined, and a proliferation index (PI) 
was calculated. The PI is the calculated expansion of a population of cells: for 
example, if 100 cells expand to 200 (regardless of distribution of generations) the PI 
is 2.0. 
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All data are presented as means. Error bars represent standard error of 
means. Differences were analyzed by analysis of variance using SAS software (SAS 
Inc., Gary, NC). Differences are considered significant at P<0.05. 
Results 
Lymphocyte blastogenesis 
Concanavalin A, PWM, PHA, and anti-CD3 MAb all caused increased uptake 
of ^H-thymidine in the lymphocyte blastogenesis assay. Figure la shows mean counts 
per minute for unstimulated PBMC and for PBMC incubated with mitogens. Anti-
CD3 was tested at a separate time, so cpm for its own controls are included. 
Mitogens were titrated to determine optimum concentrations (data not shown). The 
same concentration of mitogens was used in all subsequent assays. Blastogenesis 
stimulation indexes were calculated for each mitogen (figure lb). All mitogens 
caused significant increases in ^H-thymidine uptake compared to unstimulated 
samples (P<0.01). 
IL2r and MHC class II surface expression 
The effects of mitogens on IL2r and MHC class II surface expression on 
lymphocyte subsets are presented in figures 2-6. Con A and PWM were tested in 
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replicate wells on one occasion, PHA and anti-CD3 were tested on separate 
occasions. Values for unstimulated control cells are presented together with the 
appropriate stimulant. 
All T cell subsets (CD3^, CD4*, CDS"^, and gamma delta TCR*) responded 
to Con A, PWM, PHA, and anti-CD3 MAb with significantly increased (P<0.05) 
percentage of cells expressing IL2r and MHC 11, increased IL2r and MHC II mean 
fluorescence intensity, and increased IL2r and MHC 11 expression indexes to varying 
extents (figures 2-5). 
The percentage of B cells expressing IL2r increased significantly (P<0.05) in 
response to all mitogens. Mitogens did not increase the percentage of B cells 
expressing MHC II, since over 99% of unstimulated B cells expressed MHC 11 (figure 
6a). Con A, PWM, and anti-CD3 significantly increased IL2r mean fluorescence 
intensity of B cells (P<0.05), while PHA did not. All four mitogens caused 
significant increases in B cell MHC 11 mean fluorescence intensity (P<0.05) (figure 
6b). All the mitogens increased B cell IL2r expression index, but none caused 
changes in B cell MHC 11 expression index (figure 6c). 
Lymphocyte proliferation 
The distribution of generations of lymphocyte subsets from control, Con A, 
PWM, PHA, and anti-CD3 treated PBMC is shown in figure 7. For each series of 
bars, the first bar on the left depicts the average percentage of cells in the undivided 
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or parent generation. Bars to the right show the average percentage of cells 
containing progressively less PKH2 dye, which is interpreted as cells that have 
undergone division and are determined to be in generations 2-6. Treatments causing 
the greatest proliferation resulted in only small percentages of cells beyond the 6th 
generation, so further generations are not shown. 
The distribution of CDS"^ T lymphocyte generations is shown in figure 7a. In 
unstimulated cultures, about 75% of the CD3'^ cells are in the undivided parent 
generation after three days of incubation, with smaller numbers of cells in 
generations 2-6. The distribution of fluorescence from Con A, PHA, and anti-CD3 
treated cultures shows a shift to generations 2-6, indicating that a large percentage of 
cells proliferated. CDS"^ cells from PWM treated cultures show only a small change 
in the distribution of cell generations compared to unstimulated control cells; 61% 
remained in the parent generation. 004"^ T cells (figure 7b) and CDS"^ T cells 
(figure 7c) both proliferated noticeably to all four mitogens. The distribution of cell 
generations for both lymphocyte subsets shifted to generations 2-6 compared to 
unstimulated cells. 
CDS"^ T cell proliferation indexes (PI) are shown in figure 8a. Con A, PHA, 
and anti-CD3 stimulated cells show significantly (P<0.05) increased PI compared to 
unstimulated cells, while the PI for PWM is not significantly different (P>0.05). 
CD4'^ cells (figure 8b) and CDS"^ cells (figure 8c) responded to all four mitogens with 
significantly higher PI (P<0.05). 
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Gamma delta T cell distribution of generations is shown in figure 7d. Con A 
and PHA caused noticeable shifts to generations 2-6. The distribution of generations 
of PWM and anti-CD3 treated cells is little different than for untreated cells, 
indicating little proliferation of gamma delta T cells treated with these two 
stimulants. Gamma delta T lymphocytes treated with Con A or PHA had 
significantly increased PI (P<0.05), but PWM and anti-CD3 did not cause an increase 
in PI (figure 8d). 
B cells proliferated less than T cell subsets when incubated with stimulants. 
Con A caused a small shift to generations 2-6, but PWM, PHA, and anti-CD3 
induced little or no change compared to untreated cells (figure 7e). Fewer than 60% 
of B cells remained undivided when treated with Con A, while more than 75% of B 
cells treated with PWM, PHA, or anti-CD3 remained in the parent generation. B 
cell proliferation indexes were significantly increased only by Con A stimulation 
(P<0.05); neither PWM, PHA, nor anti-CD3 resulted in a significantly higher PI 
(P>0.05) (figure 8e). 
Discussion 
Lymphocyte blastogenesis has been used to demonstrate activation of 
lymphocytes by mitogens and antigens. However, measuring blastogenesis of 
lymphocytes that have not been separated into subsets does not identify which 
subpopulations of lymphocytes are activated. If lymphocytes are separated into 
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subsets, then tested in blastogenesis assays, the interaction of subsets cannot be 
studied. The blastogenic responsiveness of the various subsets to mitogens may be 
different when they are separated as compared to when they are incubated together 
in a mixed population. Cytokines from other subsets and cell-cell interactions may 
influence the blastogenic responsiveness of each subset. The methods employed here 
allow the quantitation of lymphocyte activation and proliferation for each subset of 
lymphocytes when they are incubated together and allowed to interact. 
Increased surface expression of IL2r and MHC II has been used in several 
species to detect mitogen and antigen activated lymphocytes (Ito et al., 1992; Hesketh 
et al, 1993; Dillender et al., 1993; Begara et al., 1995). The percentage of 
lymphocytes expressing IL2r and the density of surface IL2r expression have been 
reported to be sensitive and specific for detecting activated human lymphocytes 
(Prince et al., 1986). Single color flow cytometry has been used to study changes in 
expression of IL2r and MHC II for mitogen activated lymphocytes from healthy 
cattle, as well as from animals treated with immunosuppressive doses of 
dexamethasone (Oldham et al., 1992) and cattle with specific infectious diseases 
(Begara et al., 1995; Stone et al., 1995). Single-color analysis also has been used to 
study mitogen-induced changes in the percentage of ruminant lymphocyte subsets or 
the percentage of cells expressing surface activation markers on lymphocytes isolated 
from peripheral blood (Franklin et al., 1994; Davis et al., 1996b; Schuberth et al., 
1996), lymph nodes (Hurley et al., 1994), and bronchoalveolar lavage fluid (Begara et 
al., 1995). Two-color flow cytometry has been used to study bovine lymphoqte 
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subset expression of IL2r and MHC 11 in response to Con A and superantigen 
(Ferens et al., 1998), and the effect of viraJ infection on bovine lymphocyte subset 
expression of IL2r and MHC 11 in response to mitogens (Stone et al., 1995; Isaacson 
et al., 1998). 
In this study, the response of bovine CDS"^, CD4'", CDS"^, gamma delta T 
lymphocytes, and B cells to four commonly used mitogens was examined using three 
different methods to measure cell activation. Activation of unseparated lymphocytes 
was monitored using blastogenesis and by two-color flow cytometric detection of 
increased expression of IL2r and MHC 11 by lymphocyte subsets. Two-color flow 
cytometry was also used to directly measure proliferation of lymphocyte subsets of 
mitogen stimulated unfractionated PBMC by analyzing fluorescence intensity of 
PKH2, a fluorescent dye that incorporates into cell membranes. With each new 
generation of cells, proliferating cell populations contain progressively less PKH2 dye 
in their membranes. 
CDS"^, CD4'^, and CD8'^ T lymphocyte subsets responded similarly to Con A, 
PWM, PHA, and anti-CD3 stimulation. All three subsets had significant increases in 
the percentage of cells expressing IL2r and MHC 11, fluorescence intensity of IL2r 
and MHC n, and significant proliferative responses, except that CDS"^ cells did not 
proliferate significantly to PWM. 
Gamma delta T lymphocytes responded somewhat differently from the other T 
cell subsets to mitogenic stimulation. All the mitogens caused gamma delta T cells to 
increase surface expression of both IL2r and MHC EE. Con A and PHA induced 
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significant proliferation of gamma delta T cells. However, even though PWM and 
anti-CD3 stimulated gamma delta T cells to upregulate surface markers of activation, 
neither mitogen caused a noticeable shift in the distribution of generations or 
significantly increased PI. CDS is a pan-T cell marker found on CD4^, CDS"^, and 
gamma delta T cells (Howard et al., 1994). Gamma delta T cells comprise a large 
percentage of circulating T lymphocytes in cattle. The lack of gamma delta T cell 
proliferation in response to PWM is apparently responsible for the lack of significant 
proliferation of CDS"^ T cells to PWM, even though 004"^ and CD8* cells did have 
detectable proliferation in response to PWM. 
The lack of proliferation of gamma delta T cells to PWM may be due to 
suboptimal incubation time. In this study, PBMC were incubated with mitogens for 3 
days. A previous study found that the number of PWM stimulated bovine "null cells" 
(probably mostly gamma delta T cells) that could be recovered from culture did not 
increase until day six of incubation (Franklin et al., 1994), In the case of anti-CD3 
MAb stimulation, cross-linking of gamma delta T cell anti-CD3 molecules by MAb 
may provide sufficient stimulation to cause upregulation of IL2r and MHC IT, but not 
enough stimulation to cause proliferation. It has been shown ±at blastogenesis of 
purified bovine gamma delta T cells stimulated with aiiti-CD3 was significantly 
increased by co-stimulation with MAb against WC-1, a surface antigen found on most 
gamma delta T cells (Hanby-Flarida et al., 1996). 
Mitogen-stimulated B cells generally increased expression of activation 
markers, but proliferative responses to the mitogens varied. The percentage of B 
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cells expressing IL2r increased due to all mitogens, but only Con A, PWM, and anti-
CD3 MAb caused significant increases in IL2r fluorescence intensity. Since over 99% 
of unstimulated B cells expressed MHC 11, no increase could be seen with mitogen 
stimulation; however, all four mitogens caused increased MHC 11 fluorescence 
intensity. B cells proliferated significantly only in response to Con A, which changed 
the B cell distribution of generations and significantly increased the B cell PI. PWM, 
PHA, and anti-CD3 caused no significant proliferation of B cells. 
The results of this study appear to conflict with dogma regarding bovine 
lymphocyte subset activation by mitogens. Con A and PHA have been reported to 
stimulate bovine T cells, but not B cells, as determined by blastogenesis (Schultz, 
1981; Usinger et al., 1981). However, both Con A and PHA stimulated increased 
expression of both IL2r and MHC II in B cells when used at concentrations and 
incubations times optimal for blastogenesis. Con A was the only mitogen to cause 
noticeable proliferation of B cells. PWM treatment, which has been reported to 
induce B cell blastogenesis by a T cell dependent mechanism (Schultz, 1981), 
increased expression of activation molecules on B cells, but caused no detectable B 
cell proliferation. 
Activation of B cells in response to mitogens appears to be at least partly an 
indirect effect. Anti-CD3 MAb, which should stimulate T cells but not B cells, 
induced small but significant increases in B cell expression of activation markers. 
However, anti-CD3 did not cause significant B cell proliferation. PWM and PHA 
also induced variable upregulation of B cell activation markers, but did not cause 
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proliferation. When non-purified populations of mitogen-stimulated lymphocytes are 
incubated together, there may be enough T cell cytokine secretion or cell-cell 
interactions to stimulate B cells to increase IL2r, but not enough to cause 
proliferation after three days of incubation. Con A may have some direct effect on B 
cells. It caused upregulation of IL2r and MHC II like the other mitogens; unlike the 
other mitogens, Con A induced measurable proliferation of B cells. 
Differences were seen between expression of activation molecules and 
proliferation of some cell types, particularly gamma delta T cells and B cells. These 
differences may be due to delayed kinetics of proliferation of some subsets under the 
conditions in the study. It is also possible that incorporation of ^H-thymidine, 
expression of activation molecules, and cell division are inter-related, but do not 
necessarily provide interchangeable information. Expression of IL2r appears to be 
necessary for lymphocytes to be able to proliferate (Miyawaki et al., 1982), but 
human lymphocytes may upregulate IL2r without undergoing proliferation (Rubin et 
al., 1985). As observed with anti-CD3 stimulation of gamma delta T cells, 
upregulation of IL2r may be a necessary step towards activation, but additional 
signals may be required to enter the cell cycle and proliferate (Hanby-Flarida et al., 
1996). 
Optimal conditions for blastogenesis, activation marker expression, and 
proliferation may differ for lymphocyte subsets. It has been reported that mitogen-
stimulated ovine CD4'^, CD8"^, and gamma delta T cells have different times of 
maximum IL2r expression (Bujdoso et al., 1993). Preliminary studies in our 
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laboratory indicated that day 3 of mitogen stimulation was optimal for lymphocyte 
blastogenesis. Con A induced CD3^ T cell expression of IL2r was maximal on days 
2-4 of incubation (data not shown). Our intent was to compare activation marker 
expression and proliferation to our standard blastogenesis procedures, so optimal 
conditions for all measured parameters for all lymphocyte subsets were not 
determined. 
The results of this study indicate that when non-separated populations of 
bovine lymphocytes are incubated with Con A under conditions similar to those used 
here, resulting blastogenesis values may be attributed to proliferation of CDS*, 
CD4'^, CDS"^, and gamma delta T cells, with a small contribution from B cells. 
Blastogenesis values of complete lymphocyte populations stimulated with PHA may 
be due to proliferation of CDS"^, CD4'^, CDS"^, and gamma delta T cells, with no 
contribution from B cells. PWM blastogenesis values may be attributed to 
proliferation of CD4'^ and CDS"^ T cells, with no contribution from gamma delta T 
cells or B cells. Anti-CD3 MAb stimulated blastogenesis results may be due to 
proliferation of CD3*, CD4*, and CD8* T cells, with no contribution from gamma 
delta T cells or B cells. 
Two-color flow cytometric detection of lymphocyte subset expression of 
activation molecules and PKH2 detected proliferation are useful methods to study 
activation of bovine lymphocyte subsets. Both techniques can provide information 
regarding the responding cell types, and avoid the use of radioactive materials needed 
for blastogenesis. Both methods can detect stimulation of various lymphocyte subsets, 
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and can measure differences in response of a given subset to different stimuli. 
Measurement of increased IL2r and MHC II expression gave similar results for T cell 
subsets. Measuring expression of MHC 11 may be of little value in determining the 
activation status of B cells since even unstimulated cells express MHC n on their 
surface. 
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Table 1. Monoclonal antibodies used in this study. 
specificity monoclonal 
antibody 
isotype cell 
distribution 
reference 
CDS MMIA IgGl T cells Davis et al, 1993 
CD4 CACT138A IgGl T helper Bensaid and Hadam, 
1991 
CD4 GC50AI IgM T helper Bensaid and Hadam, 
1991 
CDS alpha CACT80C IgGl T cytotoxic Larson et al, 1990 
CDS alpha BAQlllA IgM T cytotoxic MacHugh and 
Sopp,1991 
TCRl delta chain GB21A IgG2b gamma delta T Davis et al, 1996a 
TCRl delta chain CACT61A IgM gamma delta T Davis et al, 1996a 
CD21 BAQ15A IgGl mature B cells Mukwedeya et al, 
1993 
B2 (CD21) BAQ44A IgM mature B cells Naessens and 
Howard, 1991 
CD25 (IL2r) CACTI OS A IgG2a activated T and B Naessens et al, 1992 
MHC class n TH14A IgG2a B cells 
activated T cells 
Davis et al, 19S7 
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Captions for flgures 
Figure 1. Lymphocyte blastogenesis after 3 days of incubation without stimulant 
(control), or with 2.5Mg/ml Con A, 1:500 final dilution of PWM, O.S/xg/ml PHA, or 
anti-CD3 MAb. Figure la shows mean (n=8) counts per minute for control and 
stimulated PBMC Figure lb shows mean stimulation indexes for mitogen induced 
lymphocyte blastogenesis. Error bars represent standard error of the means. (" = 
P<0.01, the level of statistical significance of the difference between the indicated 
value and the value for non-stimulated control samples). 
Figure 2. CDS"^ T cell surface expression of IL2r and MHC II when incubated 3 days 
without stimulant, or with Con A, PWM, PHA (n=5), or anti-CD3 (n=6). Figure 2a 
depicts the percentage of CD3'^ T cells expressing IL2r or MHC II. Figure 2b shows 
the mean phycoerythrin fluorescence intensity (IL2r or MHC 11 density) of CD3'^ T 
cells. Figure 2c shows the IL2r and MHC 11 expression indexes for CD3* T cells. 
Error bars represent standard errors of the means. (* = P<0.05, the level of 
statistical significance of the difference between the indicated value and the value for 
non-stimulated control samples). 
Figure 3. CD4* T cell expression of IL2r and MHC U when stimulated with Con A, 
PWM, PHA (n=5), or anti-CD3 (n=6). The percentage of CD4'^ cells expressing 
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IL2r or MHC 11 is shown in figure 3a. CD4* T cell mean fluorescence intensity of 
IL2r or MHC 11 expression is shown in figure 3b. 004"^ cell expression indexes for 
IL2r and MHC II are shown in figure 3c. Error bars represent standard errors of the 
means. (* = P<0.05, the level of statistical significance of the difference between the 
indicated value and the value for non-stimulated control samples). 
Figure 4. CDS"^ T lymphocyte expression of IL2r and MHC 11 due to stimulation 
with Con A, PWM, PHA, (n=5), or anti-CD3 (n=6). The percentage of CDS'*" T 
cells expressing IL2r and MHC II is shown in figure 4a. Mean fluorescence intensity 
of IL2r and MHC 11 expression is shown in figure 4b. CDS'^ T cell IL2r and MHC 
expression indexes are shown in figure 4c. Error bars represent standard error of the 
means. (' = P<0.05, the level of statistical significance of the difference between the 
indicated value and the value for non-stimulated control samples). 
Figure 5. Gamma delta T lymphocyte expression of IL2r and MHC H due to 
stimulation with Con A, PWM, PHA (n=5), or anti-CD3 (n=6). The percentage of 
gamma delta T cells expressing IL2r and MHC 11 is shown in figure 5a. Mean 
fluorescence intensity of IL2r and MHC 11 expression is shown in figure 5b. Gamma 
delta T cell II2r and MHC n expression indexes are shown in figure 5c. Error bars 
represent standard error of the means. (* = P<0.05, the level of statistical 
significance of the difference between the indicated value and the value for non-
stimulated control samples). 
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Figure 6. B lymphocyte expression of IL2r and MHC n when cultured for three days 
with Con A, PWM, PHA (n=5), and anti-CD3 (n=6). The percentage of B cells 
expressing IL2r and MHC 11 is shown in figure 6a. The mean fluorescence intensity 
of IL2r and MHC 11 expression is shown in figure 6b. B cell Expression indexes for 
IL2r and MHC 11 are shown in figure 6c. Error bars represent standard errors of the 
means. (• = P<0.05, the level of statistical significance of the differences between 
the indicated value and the value for non-stimulated control samples). 
Figure 7. Distribution of generations of lymphocyte subsets incubated with Con A, 
PWM, PHA, or anti-CD3 MAb. For each series of bars, the bar on the left 
represents the percentage of cells in the parent, or undivided, generation. Successive 
bars to the right represent the percentages of cells in generations 2-6. (n=8) 
Figure 8. Calculated proliferation indexes of lymphocyte subsets incubated with Con 
A, PWM, PHA, or anti-CD3. (n=8) (' = P<0.05, the level of statistical significance 
of the difference between the indicated value and the value for control non-
stimulated samples.) '^A 
65 
A. 
biastogenesis, mean counts per minute 
140000 
120000 
100000 -
E 80000 
i2 60000 -
" 40000 4 
20000 
control Con A PWM PHA control anti-CD3 
B. 
400 
X o 
•a c 
c 0 
ro 3 
1 
biastogenesis mean stimulation indexes 
100 r 
Con A PWM PHA anti-CD3 
Figure I 
66 
A. % of CDS T cells expressing IL2r and MHC II 
0) 
2 40 
• IL2r 
• MHC 
control Con A PWM control PHA control anti-
CD3 
B. CDS T cell fluorescence Intensity of IL2r and MHC II 
'</) 100 
• IL2r 
• MHC II 
control Con A PWM control PHA control anti-
CD3 
C. CDS T cell IL2rand MHC II expression indexes 
X 
•D C 
C 
(fl 
en 0) I w CL 
X 0} 
1800 
1600 
1400 
1200 
1000 
800 
600 
400 
200 
• IL2r 
• MHC 
Con A PWM PHA anti-CDS 
Figure 2 
67 
% of CD4 T cells expressing IL2r and MHC 11 
K 40 
control Con A PWM control PHA control anti-
CD3 
• IL2r 
• MHC II 
B. CD4 T cell fluorescence intensity of IL2r and MHC II 
c (U 
0} 
o c (U 
u 
V) g) 
o 3 
C 
CD (U 
E 
140 
120 
100 
80 
60 
40 
20 
0 
i 
dMI -fi—^ 
MHC 
control Con A PWM control PHA control anti-
CD3 
C. CD4 T cell IL2r and MHC II expression indexes 
X <D 
•a 
600 
500 
I 300 
<13 la 
Q. 
X 
100 
0 
i 1 
1 1 
1 
1 1 
1— 
ar-ffc-
Con A PWM PHA anti-CD3 
• IL2r 
• MHC 
Figures 
68 
; % of CDS T cells expressing IL2r and MHC II j 
1 I 
i 100 T ^^ 
- —nrm—s—\Y § I I •" 
I  4 0 -  m— I I B- BMHcii : 
^ 1 1  J l r  
control Con A PWM control PHA control anti-
CD3 
D 
i • CDS T cell fluorescence intensity of IL2r and MHC II 
control Con A PWM control PHA control anti-
CD3 
I 
CDS T cell IL2r and MHC II expression indexes 
8000 
X 6000 -
•a 
f 4000 7 
in 
CO 
• IL2r 
• MHC II 
Con A PWM PHA antl-CD3 
Figure 4 
69 
A. % of gamma delta T cells expressing IL2r and MHC II 
* * 
2 40 
• IL2r 
• MHC II 
control Con A PWM control PHA control anti-
CD3 
gamma delta T cell fluorescence intensity of IL2r and MHC II 
I « 80 
control Con A PWM contro PHA 
• IL2r 
• MHC II 
control anti-
CD3 
gamma delta T cell IL2r and MHC II expression indexes 
X d) 
•a c 
c 
o 
2000 T 
1500 
2 1000 4 M 
CO 0) 
w Q. X 0} 500 
j 
i 
! — 
T 
j J— 
T T 
! 
1 
i L • -
• IL2r 
• MHC I 
Con A PWM PHA anti-CD3 
Figure 5 
70 
A. % of B cells expressing IL2r and MHC II 
100 
80 
c 60 03 u 
K 
20 -
i 
0 4 
• IL2r 
• MHC II 
control Con A PWM control PHA control anti-
CD3 
B cell fluorescence intensity of IL2r and MHC II 
"to 500 
C 400 -i 
300 ^ 
$ 200 
• IL2r 
• MHC II 
control Con A PWM control PHA control anti-
CD3 
C. B cell IL2r and MHC II expression indexes 
2000 
X 
I 1 
c 
o in 
CO 
£ Q. 
X 0) 
1600 4-
1200 
800 
400 
• lL2r 
• MHC 
Con A PWM PHA anti-CD3 
Figure 6 
71 
A. distribution of CDS T cell generations 
P 2 34 5 6 
control 
P 2 3 4 5 6 
Con A 
P 2 3 4 5 6 
PWM 
P 2 3 4 5 6 
PHA 
P 2 34 5 6 
anti-CD3 
B. distribution of CD4 T ceil generations 
90 
80 
c 
8 
w* 0) 
a. 
P 2 3 4 5 6 
control 
P 2 34 5 6 
Con A 
P 2 3 4 5 6 
PWM 
P2 3 4 5 6 
PHA 
P2 3 4 5 6 
anti-CD3 
C. distribution of CDS T cell generations 
c 0) 
0) 
a. 
P  2 3 4  5  6  
control 
P 2 3 4 5 6 
Con A 
P2 34 5 6 
PWM 
P2 3 4 5 6 
PHA 
P2 34 5 6 
anti-CD3 
Figure 7 
72 
D. distribution of gamma delta T cell generations 
c 09 0 1 <D 
Q. 
P 2 3 4 5 6 
control 
P 2 3 4 5 6 
Con A 
P 2 34 5 6 
PWM 
P 2 3 4 5 6 
PHA 
P2 3 4 5 6 
anti-CD3 
E. distribution of B cell generations 
c 0) u bw lU 
Q. 
P 2 34 5 6 
control 
P 2 3 4 5 6 
Con A 
P 2 34 5 6 
PWM 
P 2 3 4 5 6 
PHA 
P 2 3 4 5 6 
anti-CD3 
Figure 7 (continued) 
73 
A. CD3 T cell proliferation indexes 
X a> 
•a c 
c 
o 
15 
>£ 
o 
a. 
7 
6 
5 
4 
3 
2 
1 • • 
no stim Con A PWM PHA anti-CD3 
B. CD4 T cell proliferation indexes 
X V 
•a c 
c 
.o 
w 
jg 
o W 
o. 
7 
6 
5 
4 
3 
2 
1 
0 
no stinn Con A PWM PHA anti-CD3 
CDS T cell proliferation indexes 
no stim Con A PWM PHA anti-CD3 
figtire 8 
74 
gamma delta T cell proliferation indexes 
E. B cell proliferation indexes 
X 
"D C 
c 
o 
CD w 
2 Q. 
6 
5 
a 2 
no stim Con A PWM PHA anti-CD3 
Figure 8 (continued) 
75 
CHAPTER 4. ANTIGEN SPECDFIC UP-REGULATION OF INTERLEUKIN-2 
RECEPTOR ON T LYMPHOCYTE SUBSETS OF CATTLE 
HYPERIMMUNIZED WITH BOVINE VIRAL DIARRHEA VIRUS 
A paper to be submitted to Veterinary Immunology and Immunopathology 
Mark J. Quade, Steve R. Bolin, Julia F. Rid^. - ^ and James A. Ro± 
Abstract 
Up-regulation of interIeukin-2 receptor (IL2r) on mononuclear cells from 
cattle hyperimmunized with bovine viral diarrhea virus (BVDV) was deteaed after in 
vitro stimulation with BVDV, Cattle were hyperimmunized by repeated challenge 
with different isolates of BVDV genotype 1 and genotype 2. Peripheral blood 
mononuclear cells were isolated from the hyperimmunized cattle and incubated in 
vitro for six days with or without live BVDV strain 890. Lymphocytes were analyzed 
by two-color flow cytometry. Monoclonal antibodies (MAb) labeled with fluorescein 
isothyocyanate specific for T lymphocyte surface molecules (CDS, CD4, CDS, and 
gamma delta T cell receptor (TCR)) were used to identify T cell subsets. Antigen 
specific activation of T cell subsets was determined by quantification of surface 
expression of EL2r using phycoerythrin-labeled MAb specific for IL2r. CD3*, CD4*, 
CDS'*", and gamma delta TCR"^ T cells from hyperimmunized cattle significantly 
increased expression of IL2r when incubated with BVDV, compared to cells from 
hyperimmunized cattle incubated in meditmi without BVDV. T lymphocyte subsets 
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from BVDV negative control cattle did not have measurably increased expression of 
IL2r when incubated with BVDV. 
Introdaction 
Bovine viral diarrhea virus (BVDV) is a ubiquitous pathogen of cattle, causing 
enteric, respiratory, and reproductive diseases. BVDV may be the most economically 
damaging viral infection of cattle in the United Stales (Baker, 1995). Much is known 
regarding antibody responses of cattle to BVDV, but little is reponed regarding 
antigen specific T cell responses. It has been reponed that T lymphocytes from cattle 
infected with BVDV recognize virus-specific antigen: lymphocytes isolated from 
BVDV infected cattle will proliferate when incubated in vitro with live BVDV or viral 
proteins (Larsson et aL, 1992; Lambot et aL, 1997), and virus-specific cytotoxic T 
lymphocytes (CTL) have been demonstrated (Beer et aL, 1997), 
The alpha subunit of interleukin-2 receptor (IL2r) is expressed on the surface 
of activated lymphocytes, but not resting cells (Abbas et aL, 1994; Uchiyama et aL, 
1981; Minami et aL, 1993). Activation of lymphocytes and expression of IL2r may be 
induced by mitogens, T cell specific monoclonal antibodies (MAb), or by specific 
antigen (Cantrell et aL, 1984; Smith, 1988). Increased expression of IL2r may be 
deteaed by immunohistochemistry or flow cytometry using fluorescently labeled 
monoclonal antibody (MAb) against IL2r. When used in conjunction with MAb 
against various lymphome subset markers, e.g. CD4 or CD8, it is possible to detect 
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the subset(s) of lymphocytes activated by an antigenic stimulus (Begara et al., 1995; 
Bujdoso et al., 1993). Using two-color flow cytometry, the percentage of cells in a 
lymphocyte subset expressing activation markers may be calculated. The mean 
fluorescence intensity of cells expressing activation markers, which corresponds to the 
density of activation molecules on the surface of each cell (Shapiro, 1995), also may 
be measured. Two-color flow cytometry has been used to detect antigen specific in 
vitro upregulation of IL2r of T lymphocytes in humans (Ito et al., 1992), swine 
(Dillender et al., 1993), deer (Hesketh et al., 1993), and cattle (Isaacson et al,, 1998). 
In this study, we determined the T lymphocyte subsets from hyperimmunized 
cattle that become activated when exposed to viral antigen in vitro. BVDV positive 
animals were produced by repeated challenge exposure with different isolates of 
BVDV. Calves negative for BVDV and antibody against BVDV were used as 
controls. Peripheral blood mononuclear cells (PBMC) were isolated from 
hyperimmunized and control cattle and incubated in vitro with or without live BVDV 
for six days. Two-color flow cytometry was used to identify CDS"^, CD4'^, CDS"^, or 
gamma delta T cell receptor"^ (TCR) T lymphocytes, and surface expression of IL2r. 
The magnitude of activation of each subset was determined by calculating the 
percentage of cells expressing IL2r, by measuring the mean fluorescence intensity of 
IL2r expression, and using these two parameters to calculate an IL2r expression 
mdex. 
Materials and methods 
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Animals 
Six Holstein steer calves which were hyperimmunized in order to produce 
antibody for another experiment were used as BVDV positive animals. Two 4-6 
month old steers, numbers 8 and 9, were hyperimmunized with BVDV as follows: 
animals received live BVDV strain NY-1 (genotype 1, non-cytopathic) intranasally, 
followed four weeks later by live strain 1373 (genotype 2, non-cytopathic) intranasally, 
followed four weeks later by Singer strain (genotype 1, cytopathic) soluble antigen 
(Coria et al., 1984) subcutaneously. One 3-4 month old steer, number 10, was 
hyperimmunized with BVDV strain 28508-5 (genotype 2, non-cytopathic) intranasally, 
followed four weeks later by strain NY-1 intranasally. Two 3-4 month old steers, 
numbers 11 and 12, were hyperimmunized intranasally with strain 28508-5 , followed 
four weeks later by strain NY-1 intranasally, followed four weeks later by strain 
NADL (genotype 1, cytopathic) intranasally. One 3-4 month old steer, number 13, 
was hyperimmunized with strain 28508-5 intranasally, followed by strain 1373 
intranasally, followed by strain NADL intranasally. Seven colostrum-deprived calves 
raised in isolation and negative for BVDV and antibody against BVDV were used as 
negative control animals. Beginning four weeks after the last virus challenge 
exposure, PBMC were isolated from the cattle for testing. PBMCs from each animal 
analyzed on two occasions. 
Vims 
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BVDV strain 890 (genotype 2, non-cytopathic) was used for in vitro stimulation 
of PBMC. Virus was propagated in bovine turbinate cells grown in McCoy's medium 
supplemented with 10% fetal bovine serum. Culture flasks were freeze/thawed, and 
culture medium centrifuged at 200 x g for 10 minutes to pellet cell debris. The 
supernatant was passed through a 0A5^im filter, aliquoted, and stored at -80°C. The 
resulting suspensions contained 1 x 10^ live BVDV/ml. 
Monoclonal antibodies 
Mouse monoclonal antibodies (MAb) that bind to the following bovine 
antigens were purchased from VMRD (Pullman, WA): CDS (MMIA), CD4 
(CACT138A), CD8 (CACT80C), gamma delta TCR (GB21A), alpha chain of IL2r 
(also known as CD25)(CACT108A). Anti-CD3, -CD4, and -CDS were IgGl isotype. 
Anti-gamma delta TCR was IgG2b isotype. Anti-IL2ra was IgG2a isotype. Affinity 
purified goat anti-mouse isotype specific secondary antibodies were purchased from 
Caltag (Burlingame, CA): phycoerythrin (PE) -labeled IgG2a (M32204), fluorescein 
isothiocyanate (FTTC) -labeled IgGl (M32101), and FITC-labelled IgG2b (M32501). 
Mouse monoclonal antibodies of irrelevant specificity used as isotype controls were 
purchased from Caltag: IgGl (MGIOO), IgG2a (MG2a00), and IgG2b (MG2b00). 
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Isolation and culture of PBMC: 
PBMC were isolated using a previously described method (DeBey et al., 1996), 
Briefly, citrated blood was centrifuged, the bu^ coat was collerted, and 
contaminating erythrocytes lysed by hypotonic flash lysis. PBMC were washed twice 
in HBSS without Ca"^^ and Mg^'^ (HBSS) (Celox), and resuspended at 2 x lOVml in 
5ml RPMI 1640 (10% fetal bovine serum, 0.1% tissue culture penicillin/streptomycin) 
in wells of 6-well tissue culture plates. Control cells were incubated in medium only. 
Isolated cells were >95% viable by trypan blue exclusion. Virus treated PBMC were 
incubated with live BVDV strain 890 at a multiplicity of infection (moi) of 1:2. 
PBMC incubated with 2.5/ig/ml concanavalin A and analyzed for up-regulation of 
n-2r on CDS"^ T cells only were used as positive controls. All assays were done in 
duplicate. Plates were incubated for 6 days in humidified 5% CO, atmosphere at 
39°C. 
Preparation of cultured PBMC for flow cytometry: 
At the end of the culture period, plates were chilled on ice. Cells were 
recovered by aspirating medium and non-adherent cells, which were placed into test 
tubes. Wells were rinsed with cold HBSS, and the HBSS with cells was added to the 
cells and medium initially recovered. Wells were then treated with 1 mi cold 
tiypsin/EDTA for 3-4 minutes and rinsed with cold HBSS, which was added to 
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previously recovered cells and media. Cells harvested from duplicate wells were 
pooled for further processing, A small percentage of cells remained adhered and 
could not be recovered by this method. 
Recovered cells were washed once with HBSS, then washed once in phosphate 
buffered saline containing 1% bovine serum albumin and 0.1% sodium azide 
(PBS + +) and resuspended in PBS+ + at 5 x lOVml, Cell suspension (200/il) was 
placed in wells of a 96-well u-bottom microtiter plate. Cells were pelleted by 
centrifugation at 200 x G for 1 minute, and the supernatant discarded. All cells were 
incubated with two primary MAb: MAb against a lymphocyte phenotype marker and 
MAb against IL2r. Cells in replicate wells were resuspended in 25^1 anti-IL2r 
(lO/ig/ml PBS + +) followed by 25^1 of MAb (lO/xg/ml in PBS + +) against either 
CD3, CD4, CDS, or gamma delta TCR (anti-CD4 was used at 20Mg/ml). Duplicate 
wells containing cells used as isotype controls were resuspended in 25 fil IgG2a 
isotype control MAb (control for anti-IL2r) and either 25/^1 of IgOl isotype control 
MAb (control for anti-CD3, -CD4, and -CDS), or IgG2b MAb (control for anti-
gamma delta TCR), all at lO/xg/ml PBS+ +. Cells and primary antibodies were 
incubated at 4°C for 30 minutes. Cells then were washed four times with PBS+ +, 
and resuspended in dilutions of two isotype specific secondary antibodies. All cells 
were resuspended in 25^1 of PE-labeled anti-Ig2a, followed by either 25fil FTTC-
labeled anti-IgG2b or 25^il FTTC-labeled anti-IgGl in appropriate wells. All 
secondary antibodies were diluted to lO/ig/ml PBS+ +. Cells and antibodies were 
incubated for 30 minutes at 4°C in the dark. Cells were washed five times with 
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HBSS, then fixed in 1% paraformaldehyde in PBS for flow cytometric analysis. Cell 
fluorescence was analyzed on an Epics XL-MCL flow cytometer (Coulter) equipped 
with System II (version 1.0) software. Excitation was at a wavelength of 488nm using 
an argon laser. FTTC fluorescence was measured in the FLl channel, PE 
fluorescence was measured in the FL2 channel. 
Data Analysis 
For each lymphocyte subset marker, the percentage of PBMC staining positive 
for IL2r was calculated. The mean fluorescence intensity (PE) of IL2r positive cells 
also was determined. The IL2r expression index (EI) for each T cell subset was 
calculated using this equation: 
(% of cells IL2r+) x (mean fluorescence intensity of IL2r+ cells) 
for PBMC incubated with BVDV 
(% of cells IL2r+) x (mean fluorescence intensity of IL2r+ cells) 
for same animal PBMC incubated without BVDV 
Results are expressed as means of repeated trials. Statistical significance of 
differences was determined by analysis of variance using software from SAS Inc. 
(Cary, NC) 
Results 
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When PBMC from hyperimmunized cattle were incubated with BVDV strain 
890, the percentage CD3"^ T cells, CIM"^ T cells, and gamma delta TCR"*" T cells 
expressing IL2r increased significantly (P<0.05) compared to PBMC incubated 
without virus (figures la, Ic, and Ig). CDS"^ T cells, CEM"^ T cells, and gamma delta 
TCR"^ T cells from hyperimmunized cattle did not significantly (P>0.05) increase 
IL2r fluorescence intensity when incubated with BVDV (figures lb, Id, and Ih). 
Incubation with BVDV did not cause CDS"^, 004"^, or gamma delta TCR"^ T cells 
from control animals to measurably increase (P>0.05) the percentage of cells 
expressing IL2r (figures la, Ic and Ig) or IL2r fluorescence intensity (figures lb. Id, 
and Ih). 
The percentage of CD8'^ T cells expressing IL2r increased significantly when 
PBMC from hyperimmunized cattle (P<0.05) but not from control cattle (P>0.05) 
were incubated with BVDV 890 compared to PBMC incubated in mediimi alone 
(figure le). 008"^ T cells from hyperimmunized cattle (P<0.05) but not from control 
cattle (P>0.05) significantly increased IL2r fluorescence intensity when incubated 
with BVDV when compared with cells incubated in medium alone (figure If). 
Figure 2 shows IL2r EI for T lymphocyte subsets. Expression indexes for T 
cells from hyperimmunized cattle were significantly higher than for T cells from 
control cattle for CDS"^ (P<.01), CD4"^ (P<0.05), CDS"^ (P<.01), and gamma delta 
TCR* T cells (P<0.01). 
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Con A treated CDS"^ T cells of both hyperimmunized and control cattle 
significantly increased (P<0.05) the percentage of cells expressing IL2T (figure 3a) 
and IL2r fluorescence intensity (figure 3b) compared to unstimulated cells. IL2r EI 
for €03"^ T cells were not significantly different (P>0.05) between infected and 
control groups (figure 3c). 
T cell subset IL2r EI for individual control animals are shown in figure 4a, 
Mean values are represented by columns, error bars represent the range of ±e two 
values for IL2r EI obtained for each T cell subset of each animal. Mean values for 
controls are generally below 3, with only one mean value higher than 5. Two 
individual values exceed 5. T cell subset IL2r EI for infected animals are presented 
in figure 4b. Animals 8, 9, 11, and 12 have most subset averages or individual values 
in excess of 5. Animal 13 has individual values above 5, with most average subset 
IL2r EI below 5. Animal 10 has no EI values above 4. 
Discussion 
Few reports of BVDV-specific T cell responses have been published. Antigen 
specific lymphocyte blastogenesis responses have been reported fi-om cattle naturally 
(Larsson et al., 1992) and experimentally infected (Lambot et al., 1997) with BVDV. 
A BVDV non-structural protein, p80, has been shown to induce blastogenesis of 
PBMC fi-om infected cattle (Lambot et al., 1997). Measuring blastogenesis of 
lymphocytes that have not been separated into subsets does not identify 
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subpopulations of lymphocytes activated by antigen. Lymphocytes may be separated 
into subsets, then tested in blastogenesis assays in an attempt to determine the types 
of lymphocytes that are stimulated by specific antigens (Denis et al., 1994). However, 
if lymphocytes are separated into subsets, the interaction of subsets cannot be 
studied. The blastogenic responsiveness of the various subsets to antigen may be 
different when they are separated as compared to when incubated toge±er in a 
mixed population. Cytokines produced by commingled subsets, and cell-cell 
interactions, may influence the activation and blastogenic responses of individual 
lymphocyte subsets. 
BVDV-specific CTL have been detected in PBMC from BVDV immunized 
cattle (Beer et al., 1997). Antigen specific cytotoxic activity generally is associated 
with CDS"^ T lymphocytes. However, gamma delta T cells, which represent a 
prominent percentage of circulating lymphocytes in cattle (Hein et al., 1991), are 
capable of cytotoxicity (Lang et al., 1995; Kau&nann, 1996). Even €04"^ T cells may 
be cytotoxic under some conditions (Choi et al., 1994). Hence, demonstrating 
cytolytic activity does not identify the T cell subset responsible for this function. 
During primary infection of gnotobiotic calves with BVDV, in vivo depletion of 
CD4'^ T cells with anti-CD4 MAb resulted in extended viremia and increased nasal 
shedding of virus, while depletion of CDS'*" or gamma delta TCR* T cells did not 
increase viremia or nasal shedding (Howard et al., 1992). Although these data 
demonstrated that CD4'*" T cells are important in limiting a primary BVDV infection 
in gnotobiotic calves, it is possible that CDS^ and/or gamma delta TCR* T memory 
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cells may be generated by primary infection or by vaccination, and that these subsets 
may be important in responding to second exposure to the same strain or a 
heterologous strain of BVDV. 
In this study, two-color flow cytometry was used to detect activation of BVDV 
specific lymphocytes by measuring up-regulation of IL2r on T cell subsets. 
Interleukin-2 receptor consists of 3 subunits, alpha, beta, and gamma. The beta and 
gamma subunits are expressed on resting lymphocytes and have a low affinity for IL-
2; high concentrations of IL-2 are required for sufficient binding to the beta-gamma 
complex to occur and induce lymphocyte proliferation. When lymphocytes are 
activated by binding of specific antigen to the TCR, II-2r alpha (CD25) is rapidly 
upregulated. IL2r alpha complexes with the beta and gamma subunits, forming a 
high-affinity receptor; antigen-activated lymphocytes expressing the alpha-beta-gamma 
IL2r complex are responsive to significantly lower concentrations of IL-2 than resting 
cells (Abbas et al., 1994). 
The results of this study demonstrate that cattle infected with BVDV generate 
memory CDS"^, CD4^, CDS"*", and gamma delta TCR^ T lymphocytes that recognize 
BVDV antigens and respond by upregulating IL2r. It is unknown whether the 
antigen responsive T cells were functionally active or proliferating. Wild-type BVDV 
and vaccine strains of BVDV have been shown to inhibit lymphocyte proliferation 
and suppress some leukocyte functions (Roth et al., 1983; Brown et al., 1991; Atluru 
et al., 1992). Expression of IL2r may be necessary for lymphocytes to enter the cell 
cycle and divide (Miyawaki et al., 1982), but does not mean that T cells are 
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proliferating. Human T lymphocytes may increase surface expression of IL2r without 
proliferating (Rubin et al., 1985), and mitogen stimulated bovine lymphocytes, 
particularly gamma delta T cells and B lymphocytes, may upregulate IL2r expression 
without proliferating (Quade et al., 1998). Flow cytometric detection of activated 
lymphocytes combined with proliferation assays and functional assays, such as antigen 
specific cytokine secretion or cytotoxicity, may lead to a better understanding of 
BVDV pathogenesis and the roles and interactions of the various lymphocyte 
subpopulations in the immune response of cattle to BVDV. 
Two-color flow cytometric analysis of lymphocyte phenotype and IL2r 
expression is a useful method to detect BVDV specific T cells from a population of 
hyperimmunized cattle. No published reports of T cell responses generated by 
BVDV vaccines could be found; this technique may provide a way to study the ability 
of modified-live virus and killed virus vaccines to induce BVDV specific T cell 
subsets. The ability of T cell subsets generated against a given strain of BVDV to 
recognize and protect against a heterologous strain of BVDV needs further study; the 
technique described in this study may be useful to examine T cell responses to 
heterologous and homologous strains of BVDV within genotypes 1 and 2 as well as 
between genotypes. Variability between animals and day to day variability for the 
same animal may require testing of multiple animals and multiple sampling of 
individual animals. 
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Figure 1. T lymphocyte subset IL2r expression when PBMC of uninfected control 
cattle (n=7) and BVDV hyperimmunized cattle (n=6) are incubated in vitro for six 
days in medium only or with live BVDV. The percentage of CDS"^ T cells expressing 
IL2r is shown in figure la. Figure lb depicts the IL2r fluorescence intensity of CD3^ 
T cells. The percentage of CD4* T cells expressing IL2r is shown in figure Ic, and 
CD4'*' T cell IL2r fluorescence intensity is shown in figure Id. The percentage of 
CDS"^ T cells expressing IL2r is shown in figure le and the CD8* T cell IL2r 
fluorescence intensity is shown in figure If. The percentage of gamma delta TCR"*" T 
cells expressing IL2r is shown in figure Ig, and the gamma delta TCR"^ T cell IL2r 
fluorescence intensity is shown in figure Ih. (' = P<0,05, the level of statistical 
significance of the difference between the indicated value and the value for cells 
incubated without BVDV). 
Figure 2. T cell subset IL2r expression indexes when PBMC of uninfected control 
cattle (n=7) and BVDV hyperimmunized cattle (n=6) are incubated in vitro for six 
days in medium only or with live BVDV. (" = P<0.01, * = P<0.05, the level of 
statistical significance of the difference between the value for infected animals and 
the value for control animals). 
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Figure 3. CDS"^ T cell IL2r expression when PBMC of uninfected control cattle 
(n=7) and BVDV hyperimmunized cattle (n=6) are incubated in vitro for six days in 
medium only or with Con A. Figure 3a shows the percentage of CD3^ cells 
expressing IL2r. Figure 3b shows the IL2r fluorescence intensity of €03"^ T cells. 
Figure 3c shows CD3 T"^ cell IL2r expression indexes for hyperimmunized and 
control cattle. (* = P<0.05, the level of statistical significance between the indicated 
value and the value for unstimulated cells.) 
Figure 4. T cell subset expression indexes against BVDV 890 of individual uninfected 
control cattle and cattle hyperimmunized with BVDV, Figure 4a shows T cell subset 
IL2r expression indexes for control cattle, and figure 4b shows T cell subset IL2r 
expression indexes for hyperimmunized cattle. Each group of columns represent EL2r 
expression indexes for one animal; the first column represents mean IL2r EI for 
033"^ T cells, followed by CD4*, CDS"^, and gamma delta TCR"^ T cell mean IL2r 
EI. Error bars represent the range of the two IL2r EI values for each T cell subset 
from each animal. 
% of CD3* T cells expressing IL2r 
m 
0 medium 
• BVDV 
control hyperimmunlzed 
% of CD4* T cells expressing IL2r 
control 
B medium 
• BVDV 
hyperimmunlzed 
Figure 1 
CDS T cell IL2r fluorescence intensity 
B medium 
• BVDV 
- - - I  
control hyperimmunlzed 
CD4* T cell IL2r fluorescence intensity 
El medium 
• BVDV 
control hyperimmunlzed 
% of CDS* T cells expressing IL2r 
25 
20 
15 
10 
5 
0 
B medium 
• BVDV 
control 
- t  - - -  II  I I  11^* I 
hyperimmunized 
% of gamma delta TCR^ T cells expressing IL2r 
25 
20 
15 
10 
5 
0 U . J 
B medium 
• BVDV 
control hyperimmunized 
F. 
^ 7 
6 Q> 
^ 5 0) 
c 4 0) 
o (O o 
<D ^ 
ro 1 a> 
^ 0 
CD8* T cell IL2r fluorescence intensity 
1 
B medium 
• BVDV 
control hyperimmunized 
H. 
gamma delta TCR* T cell IL2r fluorescence intensity 
« 6 
0) 
.G 5 0) 
A c 4 0) 
o (o o ^ o 
o 3 2 
c 
S 1 
E 
0 medium 
• BVDV 
control hyperimmunized 
Figure 1 (continued) 
T cell subset IL2r expression indexes 
E control 
• hyperimmunized 
CD3+ CD4+ CD8+ gamma delta+ 
iMgure 2 
100 -
80 -
60 -
40 -
20 -
0 -
70 — 
60 — 
50 — 
40 — 
30 — 
20 — 
10 — 
0 — 
1600 
1400 
1200 
1000 
800 
600 
400 
200 
0 
97 
Con A stimulation, % of CDS" T cells expressing lL2r 
control hyperimnnunized 
0 mdium 
• Con A 
Con A stimulation, CDS* T cell IL2r fluorescence intensity 
0 medium 
• Con A 
control hyperimmunized 
Con A stimulation, CDS"! cell IL2r expression indexes 
control hyperimmunized 
Figure 3 
98 
control cattle, T cell subset IL2r expression indexes 
X o 
"O c 
c 
o 
CO 
S 
a. 
o 
35 
30 
25 
20 
15 
10 
5 
0 
r 
r7-r-n 1b 1^ "l"! 1 
0CD3+ 
• CD4+ 
• CD8+ 
• gamma detta+ 
B. BVDV hyperimmunized cattle, T cell subset IL2r expression indexes 
X o 
•o 
c 5 CO 
9) 
2 
o. X (S 
aCD3+ 
aCD4+ 
• CD8+ 
• gamma delta+ 
10 11 12 13 
Figure 4 
99 
CHAPTER 5. ANTIGEN SPECIFIC IN VITRO ACTIVATION OF T LYMPHOCYTE 
SUBSETS OF CATTLE IMMUNIZED WITH A MODIFIED-LIVE BOVINE 
HERPESVIRUS 1 VACCINE 
A paper to be submitted to Viral Immunology 
Mark J. Quade and James A, Roth 
Abstract 
Bovine peripheral blood mononuclear cells from cattle immunized with a 
modified-live virus bovine herpesvirus 1 (BHVl) vaccine and from BHVl negative 
cattle were incubated in vitro with inactivated BHVl for six days. Antigen specific 
activation of T lymphocyte subsets was measured by two-color flow cytometric 
analysis of T cell phenotype and surface expression of interleukin-2 receptor (IL2r). 
Vaccinated animals, but not unvaccinated animals, had CDS"^, 004"^, and gamma 
delta T cells that significantly (P<0.05) increased expression of IL2r when incubated 
with BHVl. CDS"^ T cells from vaccinated animals did not consistently increase IL2r 
expression when incubated with inactivated BHVl. 
Introduction 
Bovine herpesvirus type 1 (BPTVl) is a major cause of respiratory and 
reproductive disease in cattle. Humoral immune responses to BHVl are relatively 
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well known, while T cell immune responses are less well characterized. Antigen-
specific lymphocyte blastogenesis (Griebel et al., 1988) and cytokine secretion in vitro 
(Tikoo et al., 1995) have been demonstrated. Antigen specific CD4^ T cells (Tikoo 
et al., 1995), and cytotoxic T cells (Leary et al., 1992) have also been reported. 
Depletion and enrichment of lymphocyte subsets have been used to tiy to determine 
which T cell subsets are responding to BHVl antigens (Griebel et al., 1988; Denis et 
al., 1994). Single color flow cytometry has revealed that actively infected cattle have 
reduced numbers of CDS"^ T cells in the blood (Griebel et al., 1988), and that 
interleukin-2 receptor expression may be increased on peripheral blood mononuclear 
cells (PBMC) isolated fi-om infected animals (Lan et al., 1996). Some viral gene 
products recognized by T lymphocytes have been identified (Denis et al., 1993; Leary 
et al., 1992; Tikoo et al., 1995). 
fnterleukin-2 receptor (IL2r) is expressed on the surface of activated 
lymphocytes, but not resting cells (Uchiyama et al., 1981; Minami et al., 1993). 
Activation of lymphocytes and expression of IL2r may be induced by mitogens, T cell 
specific monoclonal antibodies (MAb), or by specific antigen (Cantrell et al., 1984; 
Smith, 1988). Increased expression of IL2r may be detected by 
immunohistochemistry or flow cytometry using fluorescently labeled MAb against 
IL2r. When used in conjunction with MAb against various lymphocyte subset 
markers, e.g. CD4 or CD8, it is possible to tell which subset(s) of lympho<ytes are 
activated by an antigenic stimulus (Begara et al., 1995; Bujdoso et al., 1993). Using 
two-color flow cytometry, the percentage of a given lymphocyte subset expressing the 
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activation marker IL2r may be calculated. The mean fluorescence intensity of cells 
expressing activation markers, which corresponds to the number of activation 
molecules on the surface of each cell (Shapiro, 1995), may also be measured. Two-
color flow cytometry has been used to detect in vitro activation of antigen-specific T 
lymphocytes in humans (Ito et al., 1992), swine (Dillender et al., 1993), deer (Hesketh 
et al., 1993), and cattle (Isaacson et al., 1998). 
In this study, we have attempted to characterize T lymphocyte subset 
responses of cattle to BHVl following immunization with a modified live virus 
vaccine. PBMC isolated from vaccinated cattle and from unvaccinated control cattle 
negative for BHVl antibody were incubated with or without inactivated BHVl in 
vitro. T lymphocytes (003"^) and T lymphocyte subsets CD4^, CD8^, and gamma 
delta T cell receptor (TCR)"*" were analyzed by two-color flow cytometry to determine 
the degree of activation of each subset. Activation was measured by determining the 
percentage of cells of each subset expressing IL2r, measuring the mean fluorescence 
intensity of IL2r expression, and calculating an IL2r expression index (EI) for each 
subset. 
Materials and methods 
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Animals 
Five Holstein steers 3-4 months old were immunized with a commercially 
available vaccine (Bayer, Shawnee Mission, KS) containing modified live (MLV) 
BHVl, bovine viral diarrhea virus (BVDV), bovine respiratory syncytial virus 
(BRSV), and parainfluenza type 3 virus (PI-3). A booster dose was given 14 days 
later, as recommended on the label for inununity against BRSV. Ten calves that 
tested negative for BVDV and BHVl antibody were used as a pool of negative 
control animals. PBMC were isolated from vaccinated calves on the day of 
vaccination (day 0). Control cattle were not sampled on day 0. Beginning two weeks 
following initial vaccination, PBMC were isolated once per week until seven weeks 
after vaccination fi-om all vaccinated cattle and three control cattle. 
Vuus 
Stock BHVl was propagated in Madin Darby Bovine Kidney (MDBK) cells 
cultured in Dulbecco's modified Eagle's medium (Sigma) containing 2% fetal bovine 
serum and gentamicin (SO/ig/ml) for 24 hours at 37°C in humidified 5% COj 
atmosphere. Culture flasks were freeze-thawed and medium and cells were briefly 
sonicated to disrupt any remaining cells. Culture medium was centrifuged at 500 x G 
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for ten minutes and passed through a 0.45/im filter to remove cell debris. The 
remaining medium containing BHVl virus was heated at 56°C for 30 minutes to 
inactivate virus, aliquoted and stored at -80°C. Virus concentration was determined 
by plaque assay. The virus preparation contained 1 x 10® plaque forming units/ml. 
Monoclonal antibodies 
Mouse monoclonal antibodies (MAb) that bind to the following bovine 
antigens were purchased from VMRD (Pullman, WA): CDS (MMIA), CD4 
(CACT138A), CDSa (CACT80C), delta chain of gamma delta T cell receptor 
(GB21A), and alpha chain of IL2r (also icnown as CD25)(CACT108A). Anti-CD3, -
CD4, and -CD8, were IgGl isotype. Anti-IL2r was IgG2a isotype. Anti-gamma delta 
T cell receptor (TCR) was IgG2b isotype. Affinity purified goat anti-mouse isotype 
specific secondary antibodies were purchased from Caltag (Burlingame, CA): 
phycoerythrin(PE)-labeled IgG2a (M32204), fluorescein isothyocyanate (FTTC)-
labeled IgGl (M32101), and FITC-labeled IgG2b (M32501). Mouse monoclonal 
antibodies of irrelevant specificity used as isotype controls were purchased from 
Caltag: IgGl (MGIOO), IgG2a (MG2a00), and IgG2b (MG2b00). 
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Isolation and culture of PBMC: 
Peripheral blood mononuclear cells were isolated using a previously described 
method (DeBey et al., 1996). Briefly, citrated blood was centrifuged, the bu^ coat 
was collected, and contaminating erythrocytes lysed by hypotonic flash lysis. PBMC 
were washed twice in HBSS without Ca"^ ^ and Mg"^ (HBSS) (Celox), and 
resuspended at 2 x 10®/ml in 5ml RPMI 1640 (Celox) containing 10% fetal bovine 
serum (tested negative for BVD virus and antibody) (Hyclone) and 0,1% tissue 
culture penicillin/streptomycin (RPMI+) in wells of 6-well tissue culture plates. 
Isolated cells were >95% viable by trypan blue exclusion. Antigen stimulated PBMC 
were incubated with 25/xl of heat-inactivated BHVl preparation, a multiplicity of 
infection of 1:4. The optimal ratio of BHVl antigen to PBMC was determined in 
preliminary trials using lymphocyte blastogenesis (data not shown). Unstimulated 
control cells were incubated in medium only. Cells incubated with 2.5/ig/ml 
Concanavalin A (Con A Sigma) were used as positive controls. All wells were set up 
in duplicate. Plates were incubated in humidified 5% COj atmosphere at 39°C for six 
days. 
Preparation of cultured PBMC for flow cytometry: 
At the end of the culture period, plates were chilled on ice. Cells were 
recovered by aspirating medium and non-adherent cells, which were placed into test 
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tubes. Wells were rinsed with cold HBSS, and the HBSS with cells added to the cells 
and medium recovered initially. Wells were then treated with 1 ml cold 
trypsin/EDTA for 3-4 minutes and rinsed with cold HBSS, which was added to 
previously recovered cells and media. Cells harvested from duplicate wells were 
pooled for further processing. A small percentage of cells remained adhered and 
could not be recovered by this method. 
Recovered cells were washed in HBSS, then washed and resuspended in 
phosphate buffered saline containing 1% bovine serum albumin and 0.1% sodium 
azide (PBS + +) at 5 x 10®/ml. Cells (200mI) were placed in wells of a 96-well u-
bottom microtiter plate, pelleted by centrifugation at 200 x G for 1 minute, and the 
supernatant discarded. All cells were incubated with two primary antibodies: a T cell 
subset specific MAb and MAb against IL2r. Cells were resuspended in 25^1 MAb 
against either CD3, CD4, CDS, or gamma delta TCR, all at 10/xg/ml PBS+ + (except 
anti-CD4 was 20Mg/ml). Wells then received 25^1 anti-IL2r (lOjug/ml PBS+ +). 
Isotype control cells were resuspended in 25 /il IgG2a isotype control (control for 
anti-Il2r) and 25/il of either IgGl isotype control (control for anti-CD3, -CD4, and -
CDS) or IgG2b (control for anti-gamma delta TCR), all at lO/xg/ml. Con A 
stimulated cells were stained for CD3 and IL2r expression only. Cells and primary 
antibodies were incubated at 4''C for 30 minutes. Cells were then washed four times 
with PBS+ +, and resuspended in dilutions of two appropriate isotype specific 
secondary antibodies at lO^g/ml PBS + +; 25^1 of phycoerythrin-labeled anti-Ig2a and 
25nl FTTC-labeled anti-IgG2b, or anti-IgG2a and anti-IgGl. Cells and antibodies 
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were incubated for 30 minutes at 4°C in the dark. Cells were washed five times with 
HBSS, then fixed in 1% paraformaldehyde in PBS for flow cytometric analysis. 
Cell fluorescence was analyzed using an Epics XL-MCL flow cytometer 
(Coulter) equipped with System 11 (version 1.0) software. Excitation was by argon 
laser at 488/im, with FTTC fluorescence measured in the FLl channel, PE 
fluorescence measured in the FL2 channel. Lymphocytes were discriminated by 
forward and side light scatter properties. Ten thousand cells were analyzed for each 
sample. Settings for Quad-stat gates were determined using isotype control samples. 
Data Analysis 
For each T lymphocyte subset, the percentage of cells staining positive for 
IL2r (PE positive) was calculated. The mean fluorescence intensity (PE) of IL2r 
positive cells was also determined. The IL2r expression index (EI) was calculated 
using this equation: 
(% of cells IL2r+) x (mean fluorescence intensity of IL2r+ cells) 
for cells incubated with BHVl 
(% of cells IL2r+) x (mean fluorescence intensity of IL2r+ cells) 
for cells incubated without BHVl 
Results are presented as means. Error bars represent standard error of the means. 
Significance of differences of percent IL2r expression, IL2r fluorescence intensity, and 
IL2r expression indexes were determined by analysis of variance using software from 
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SAS Inc. (Gary, NC). IL2r expression index results were converted to log base 2 for 
statistical analysis. 
Results 
The percentage of CD3^ T cells expressing IL2r when PBMC from vaccinated 
cattle were incubated with BHVl, compared to cells incubated without antigen, 
significantly increased (P < 0.05) at all times tested except on the day of vaccination, 
day 0 (figure la). For CDS"^ T cells from unvaccinated cattle, the percentage of cells 
expressing IL2r when incubated with heat-inactivated BHVl showed a small but 
statistically significantly increase compared to control cells only on week 6 (figure la). 
Mean fluorescence intensity of IL2r expression of CDS"^ T cells for vaccinated cattle 
when incubated with BHVl was significantly increased (P<0.05) from weeks 3-7 after 
immunization, compared to samples incubated without virus. IL2r fluorescence 
intensity of unvaccinated cattle CDS"^ T cells was significantly increased (P<0.05) by 
incubation with BHVl on weeks 3, 4, and 7, however the increase on these weeks 
was smaller than that observed for vaccinated animals (figure lb). IL2r EI for 01)3 
T cells from vaccinates were significantly higher (P<0.05) than unvaccinated animals 
from weeks 2-7 post-vaccination (figure Ic). 
The percentage of €04"^ T cells expressing IL2r when PBMC from vaccinated 
cattle were incubated with antigen, compared to unstimulated cells, increased 
significantly (P<0.05) compared to PBMC not incubated with antigen on weeks 2, 3, 
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4, 6, and 7 following vaccination. The percentage of 004"^ cells expressing I12r when 
PBMC from control cattle were incubated with BHVl did not significantly increase 
(P>0.05) at any time tested (figure 2a). Vaccinated animal 004"^ T cell IL2r 
fluorescence intensity increased significantly (P<0.05) when incubated with BHVl 
from weeks 3-7, while control animal cells IL2r fluorescence intensity increased 
significantly only on week 4 (figure 2b). Vaccinated cattle 004"^ cell IL2r EI were 
significantly greater (P<0.05) than unvacdnated cattle on weeks 2, 3, 4, 6, and 7 
(figure 2c). 
The percentage of CD8* T cells expressing IL2r when PBMC from vaccinated 
calves were incubated with BHVl showed a small but significant (P<0.05) increase 
only on week 2, while the percentage of control cattle CDS* cells expressing IL2r did 
not significantly increase (P>0.05) at any time (figure 3a). CDS"^ T lymphocytes 
from vaccinates' had significant increases (P<0.05) in fluorescence intensity of IL2r 
expression on weeks 2, 3, 4, 6, and 7. Control animals CDS'* cells did not 
significantly increase IL2r fluorescence intensity at any time (figure 3b). Vaccinated 
calves' CDS* T cell IL2r EI were significantly greater (P<0.05) than unvacdnated 
cattle only at week 2 (figure 3c). 
The percentage of gamma delta T cells expressing IL2r when PBMC from 
vacdnated cattle were incubated with BHVl antigen, compared to unstimulated cells, 
increased significantly (P<0.05) at all times post-vaccination. The percentage of 
unvacdnated control animal gamma delta T cells expressing IL2r increased 
significantly (P<0.05) only on week 6 (figure 4a). This increase was much smaller 
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than that observed for the vaccinated cattle. Gamma delta T cells from vaccinates 
had significantly increased (P<0.05) fluorescence intensity of IL2r expression from 
weeks 3-7, while control cattle gamma delta T cell fluorescence intensity increased 
only on week 4 (figure 4b). Gamma delta T cell IL2r EI for vaccinated cattle were 
significantly greater (P<0.05) than unvaccinated calves on weeks 2, 3, 4, 6, and 7 
(figure 4c). 
Concanavalin A stimulation significantly increased (P<0.05) the percentage of 
003"^ T lymphocytes from vaccinated and unvaccinated cattle expressing IL2r and 
the fluorescence intensity of IL2r expression at all times tested (figures 5a and 5b). 
Con A stimulated IL2r EI for vaccinates and controls were not significantly different 
(P>0.05) at any time tested (figure 5c). 
Figure 6 depicts IL2r EI values for lymphocyte subsets of individual cattle on 
each test day in order to show day to day and animal to animal variability of the 
assay. T cell IL2r expression indexes for vaccinates (figures 6a, 6b, 6c, 6d, 6e) 
showed week to week variability, with values often in excess of 10, and several values 
greater than 20 for CD3^, 004"^, and gamma delta T cells. Only two values for 
CDS"^ T cells exceeded 10. Four of the five vaccinates (figures 7a, 7b, 7d, 7e) had 
two or more IL2r EI greater than 10 for both €04"^ and gamma delta T cells. 
Vaccinate #3 (figure 6c) had no 004"^ T cell IL2r expression indexes greater than 
10, but all gamma delta T cell values exceeded 10. In contrast, vaccinate number 1 
(figure 6a) generally had higher IL2r EI for CD4'^ cells than for gamma delta T cells. 
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T cell subset IL2r EI for control cattle (figures 6f, 6g, 6h) were generally less than 4 
for all subsets, with only 2 values greater than 10. 
Discussion 
BHVl-specific memory T cells may be deteaed in a number of ways. 
Delayed-type hypersensitivity (Bradshaw et al., 1996), lymphocyte blastogenesis 
(Griebel et al., 1988), antigen specific cytokine production (Tikoo et al., 1995), and 
cytotoxic T lymphocyte (CTL) assays (Leaiy et al., 1992; Campos et aL, 1992) have 
been used to demonstrate T lymphocyte responses to BPfVl antigens in infeaed 
cattle. Vaccine induced BHVl-specific T cell-mediated immune responses have been 
deteaed using blastogenesis (Denis et aL, 1994; Roth et al., 1998), CTL assays 
(Splitter et al., 1988), and cytokine production (Tlkoo et al., 1995). These techniques 
have been used to help identify BHVl epitopes to which T lymphocytes respond 
(Leary et aL, 1992; Denis et al., 1993; Tikoo et aL, 1995; Van Drunen Littel-Van den 
Hurk et aL, 1995). 
In this study, antigen-specific lymphocyte subset activation by BHVl was 
measured by two-color flow cytometric detection of increased expression of IL2r. 
Interleukin-2 receptor consists of three subunits: alpha, beta, and gamma. The beta 
and gamma subimits are expressed on resting lymphocytes and have a low affinity for 
IL-2; high concentrations of IL-2 are required for sufficient binding to the beta-
gamma complex to occur and induce lymphocyte proliferation. When lymphocytes 
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are activated by binding of specific antigen to the TCR, IL2r alpha (CD25) is rapidly 
upregulated. IL2r alpha complexes with the beta and gamma subunits, forming a 
high-affinity IL-2 receptor. Antigen activated lymphocytes expressing the alpha-beta-
gamma IL2r complex are responsive to much lower concentrations of IL-2 than 
resting cells (Abbas et al., 1994). 
Cattle immunized against BHVl with a modified-live vaccine developed CDS"^, 
CIX" ,^ and gamma delta T cells that responded to inactivated BHVl antigen in vitro 
by upregulation of IL2r. T lymphocytes firom non-immunized BHVl negative cattle 
did not increase expression of IL2r when incubated with BHVl antigen. This method 
allows antigen-responsive T cell subsets to be identified without separating 
lymphocytes into subsets before exposure to antigen. 
CDS"^ T cells from vaccinated animals did not respond to BHVl. The 
percentage of CDS"^ cells expressing IL2r did not increase when incubated with 
BHVl, but there were occasional small significant (P<0.05) increases in the 
fluorescence intensity of CD8* T cell E2r expression. This may be due to CDS"^ T 
cells being activated by other antigens in vivo and expressing IL2r prior to isolation, 
then increasing the density of IL2r expression in vitro because of cytokine secretion 
by, or interaction with, BHVl responsive 004"^ or gamma delta T cells. 
It is possible that the modified-live vaccine did not generate BHVl-responsive 
CDS'*" cells. It seems more likely that since the BHVl preparation used for in vitro 
stimulation was heat inactivated the BHVl antigens were not processed and 
presented appropriately on MHC I molecules to stimulate CD8+ T cells. The 
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inactivated BHVl would most likely be processed by antigen-presenting cells via the 
exogenous antigen pathway and primarily be presented by MHC class II molecules, 
which would be recognized by CD4* T cells. CD8^ T cells recognize jintigen in the 
context of MHC I, which primarily presents antigens produced by a live virus 
replicating within the antigen-presenting cell and processed by the endogenous 
pathway. The heat inactivated BHVl antigen used in vitro would probably not be 
processed by the endogenous pathway and be presented on MHC I molecules to a 
sufficient extent to stimulate CDS"^ T cells. 
Our laboratory has attempted without success to demonstrate BHVl specific T 
lymphocyte responses from infected and vaccinated animals using live BHVl as an w 
vitro stimulant. No references could be found that describe using live BHVl as an m 
vitro lymphocyte stimulant. Both live and inactivated BHVl are reported to prevent 
proliferation and cause apoptosis of bovine PBMC (Hanon et al., 1996; Hanon et al., 
1997), and live BHVl preferentially causes apoptosis of CD4'^ lymphocytes but not 
CDS"^ or gamma delta T cells (Eskra et al., 1997). Additionally, live BHTVl, but not 
inactivated virus, has been shown to inhibit lymphocyte expression of MHC I (Nataraj 
et al., 1997), which could interfere with CDS"^ T cell recognition of BHVl antigens. 
Inhibition of MHC I expression and induction of apoptosis of CD4'^ cells may 
account for the inability to use live BHVl as an in vitro stimulant. It may be 
necessary to transfect BHVl genes into cell lines (Leary et al., 1992) to study 
presentation of endogenous antigen to CDS"^ T cells. 
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There was considerable day to day and animal variability in the pattern of T 
cell subset activation and in the amount of subset IL2r expression increase. All of 
the vaccinates developed antigen-responsive CD3^ T cells. CD3^ is a pan-T 
lymphocyte marker, and is found on CD4'^, CD8^, and gamma delta T cells (Davis et 
al., 1993). Four of the five vaccinated animals generated CD4^ T cells that 
responded to inactivated BHVl, and all five vaccinates developed gamma delta T 
cells that responded in varying degrees to BHVl in vitro. One vaccinated animal 
(vaccinate #3, figure 6c) seemed to develop primarily gamma delta T cells that 
recognized BHVl, with little or no response from 004"^ T cells. Conversely, one 
animal (vaccinate #1, figure 6a) developed a stronger 004"^ T cell response, as 
compared to the gamma delta T cell response. T cell subsets from unvaccinated 
control animals did not increase IL2r expression when incubated with BHVl, except 
for a few isolated values. The few values that did increase were still generally lower 
than values generated from vaccinated animals, and probably reflect the inherent 
variability of the assay method. This technique can identify antigen-specific T cell 
subset activation in an immunized population, but variability may limit its usefulness 
for detection of infected or vaccinated individuals based on a one-time test. 
T cells from BHVl vaccinated animals were activated by heat-killed BHVl in 
vitro to have increased surface expression of IL2r. Flow cytometric detection of T 
cell subset upregulation of UJ2T identifies antigen-responsive lymphocytes, but does 
not determine the proliferative status of the responsive T cells, IL2r expression 
appears to be necessary for lymphocytes to proliferate (Miyawaki et al., 1982), but 
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bovine lymphocytes may upregulate IL2r without proliferating (Quade et al,, 1998). 
Neither does IL2r expression determine the functional status of antigen responsive T 
cells. Perhaps a combination of IL2r expression, assays that identify which subsets 
are proliferating (Quade et al., 1998), and antigen-induced function, such as cytokine 
production, will yield the most complete picture of the bovine immune response to 
BHVl. 
Two-color flow cytometry is a useful method to monitor T cell responses of a 
population to BHVl vaccination. The technique provides information regarding the 
cell types that are responding, and avoids the use of radioactive materials needed for 
lymphocyte blastogenesis. It can detect differences in stimulation of various T cell 
subsets, and can measure individual differences in subset responsiveness between 
animals. It may be a useful technique to identify T cell epitopes and study the 
efficacy of new technologies that allow vaccine antigens to activate T lymphocytes or 
specific T cell subsets to direct specific immune responses (Bona et al,, 1998). 
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Figure 1. CD3^ T lymphocyte surface expression of IL2r of vaccinated (n=5) and 
unvaccinated (n=3) cattle PBMCs incubated with or without inactivated BHVl for 6 
days. Cattle were vaccinated on day 0 and PBMCs isolated at indicated intervals 
after vaccination for testing. The percentage of CDS"^ T cells expressing IL2r is 
shown in figure la. Figure lb shows the IL2r mean fluorescence intensity of CDS"^ T 
cells. CDS"^ T cell IL2r expression indexes are depicted in figure Ic. Error bars 
represent standard errors of the means. (For figures la and lb, ' = P<0.05, the level 
of statistical significance of the difference between the indicated value and the value 
for cells incubated without BHVl. For figure Ic, ' = P<0.05, the level of statistical 
significance of the difference between the indicated value for vaccinated cattle as 
compared to unvaccinated cattle.) 
Figure 2. CD4'^ T lymphocyte surface expression of IL2r for vaccinated (n=5) and 
unvaccinated (n=3) cattle PBMCs incubated with or without inactivated BHVl for 6 
days. The percentage of CD4'^ T cells expressing IL2r is shown in figure 2a. CD4'^ 
T cell mean IL2r fluorescence intensity is shown if figure 2b. TL2T expression indexes 
of CD4'^ T cells is shown in figure 2c. Error bars represent standard errors of the 
means. (For figures 2a and 2b, * = P<0.05, the level of statistical significance of the 
difference between the indicated value and the value for cells incubated without 
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BHVl. For figure 2c, * = P<0.05, the level of statistical significance between the 
indicated value for vaccinated cattle as compared to unvaccinated cattle.) 
Figure 3, CDS"^ T lymphocyte surface expression of IL2r for vaccinated (n=5) and 
unvaccinated (n=3) cattle PBMCs incubated with or without inactivated BHVl for 6 
days. The percentage of CD8'^ T cells expressing IL2r is shown in figure 3a. CD8^ 
T cell IL2r mean fluorescence intensity is shown in figure 3b. IL2r expression 
indexes of CDS"^ T cells is shown in figure 3c. Error bars represent standard errors 
of the means. (For figures 3a and 3b, * = P<0.05, the level of statistical significance 
of the difference between the indicated value and the value for cells incubated 
without BHVl. For figure 3c, ' = P<0.05, the level of statistical significance of the 
difference between the indicated value for vaccinated cattle as compared to the value 
for unvaccinated cattle.) 
Figure 4. Gamma delta T cell surface expression of IL2r for vaccinated (n=5) and 
unvaccinated (n=3) cattle PBMC incubated with or without inactivated BHVl for 6 
days. The percentage of gamma delta T cells expressing IL2r is shown in figure 4a. 
Gamma delta T cell IL2r fluorescence intensity is shown in figure 4b. IL2r 
expression indexes of gamma delta T cells is shown in figure 4c. Error bars represent 
standard errors of the means. (For figures 4a and 4b, • = P<0.05, the level of 
statistical significance of the difference between the indicated value and the value for 
cells incubated without BHVl. For figure 4c, * = P<0.05, the level of statistical 
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significance of the difference between the indicated value for vaccinated cattle and 
the value for unvaccinated cattle.) 
Figure 5. CD3^ T cell surface expression of IL2r for vaccinated (n=5) and 
unvaccinated (n=3) cattle PBMC incubated with or without Con A for 6 days. The 
percentage of CD3'*' T cells expressing IL2r is shown in figure 5a. CDS"^ T cell IL2r 
fluorescence intensity is shown in figure 5b. CDS"^ T cell expression indexes are 
shown in figure 6c. Error bars represent standard errors of the means. (' = P<0.05, 
the level of statistical sigruficance of the difference between the indicated value and 
the value for cells incubated without Con A.) 
Figure 6. Individual calf IL2r expression indexes for all T cell subsets at each time 
tested. Values for vaccinated calves are shown in figures 6a-6e. Control animal 
values are shown in figures 6f-6h. For each T cell subset of vaccinates, the first 
column represents day 0 (day of vaccination) values, and successive columns to the 
right represent weeks 2-7 post-vaccination. For control cattle, columns represent 
weeks 2-7. (Data for week 6 are missing for vaccinate #4.) 
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CHAPTER 6. RESEARCH SUMMARY AND GENERAL CONCLUSIONS 
Summaiy of experimental results 
This dissertation describes experiments investigating in vitro detection of 
lymphocyte subsets activated by stimulation with mitogens or specific antigens. The 
role of T cell mediated immune responses (CMI) in immunity to and pathogenesis of 
many diseases is poorly characterized. Some techniques for investigating CMI, such 
as lymphocyte blastogenesis, can detect activation of T lymphocytes, but cannot 
identify the subpopulation(s) of lymphocytes that are responding. In order to more 
fully understand how the immune system responds to infection or vaccination, 
methods must be devised to specifically identify the subsets of lymphocytes that 
respond to antigen and determine their function. 
Stimulation of bovine peripheral blood mononuclear cells with mitogens 
The initial step of this research was to adapt two-color flow cytometric analysis 
of lymphocyte phenotype and activation marker expression for use with bovine 
peripheral blood mononuclear cells (PBMC) in our laboratory. Stimulation of bovine 
PBMC with mitogens caused measurable upregulation of the activation markers 
Interleukin-2 receptor (IL2r) and major histocompatibility complex n (MHC 11) 
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molecules to varying degrees on most lymphocyte subsets, thereby validating the 
ability of the technique to measure differences of activation of lymphocyte subsets. 
In the course of developing the assay, it was noted that the percentages of 
lymphocyte subsets recovered from cultures of mitogen stimulated PBMC were 
different from subset percentages from unstimulated cells. It appeared that some 
subsets had proliferated and other subsets had been reduced in number compared to 
unstimulated PBMC. The patterns of apparent proliferation were contradictory to 
the reported effects of lymphocyte subset proliferation due to mitogens. It was 
decided to investigate these results further. 
Others have determined the proliferative effects of mitogens on lymphocyte 
subsets by deleting certain lymphocyte populations before performing lymphocyte 
blastogenesis tests. Using these methods, it was concluded that Concanavalin A (Con 
A) and phytohemagglutinin (PHA) stimulate bovine T cells, and pokeweed mitogen 
(PWM) stimulates bovine T and B cells (Usinger et al., 1981). Mitogen effects on 
gamma delta T cells have been poorly characterized. Due to lymphocyte subset 
cytokine secretion and cell-cell interactions, lymphocyte subset responses to mitogens 
may be different when incubated together, compared to a purified population or a 
population depleted of certain subsets. 
In order to directly measure proliferative responses of lymphocyte subsets 
incubated together, isolated PBMC were stained with PKH2 fluorescent membrane 
dye before being placed in incubation. Proliferating lymphocytes contain 
progressively less PKH2 and decreased membrane fluorescence with each successive 
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generation. At the end of incubation, recovered cells were incubated with subset 
specific monoclonal antibodies (MAb), and flow cytometry was used to detect cell 
phenotype and relative membrane PKH2 fluorescence. 
The results of the comparison of mitogen induced lymphocyte subset 
activation marker expression and proliferation were interesting. While all the 
lymphocyte subsets responded to Con A, PHA, PWM, and anti-CD3 MAb with 
generally increased expression of IL2r and MHC II, subset proliferation varied. It 
was concluded that, under conditions similar to those used in the experiment, B cell 
proliferation is induced only by Con A. Con A and PHA induce proliferation of 
CDS"^, CD4'^, CDS"^, and gamma delta T cells. Pokeweed mitogen stimulates 
proliferation of CD4'^ and CDS"*" T cells, but not gamma delta T cells. Pokeweed 
mitogen also failed to stimulate significant proliferation of CDS"^ T cells since they 
gamma delta T cells comprise a large percentage of total T cells in cattle. Anti-CD3 
MAb stimulates proliferation of CD3*, CD4'^ and CDS"^ lymphocytes, but not gamma 
delta T cells. Although neither PWM nor anti-CD3 MAb caused measurable 
proliferation of gamma delta T cells (a large percentage of the CD3'^ cell 
population), anti-CD3 MAb caused significant proliferation of CDS"^ T cells while 
PWM did not. Apparently, proliferation of CD4'^ and CDS"^ T cells due to anti-CD3 
MAb is sufficiently greater compared to proliferation induced by PWM that the effect 
on the total CD3^ T cell population is detectable. 
Mitogenic activation of B lymphocytes may be partly an indirect effect. Anti-
CD3 MAb, which should stimulate T cells but not B cells, induced small but 
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significant increases in B cell expression of activation markers, but did not cause 
measurable B cell proliferation. PWM and PHA also induced variable upregulation 
of B cell IL2r and MHC n without causing proliferation. However, Con A may have 
some direct effect on B cells. Like the other mitogens, it caused increased expression 
of IL2r and MHC 11; unlike the other mitogens, Con A induced measurable 
proliferation of B cells. 
Stimulation of PBMC with bovine viral diarrhea virus 
An experiment was designed to test the hypothesis that cattle infected with 
bovine viral diarrhea virus (BVDV) develop BVDV specific T lymphocytes, and that 
these antigen specific T cells can be detected in vitro. Calves that had been 
hyperimmunized (for other purposes) by repeated intranasal challenge with different 
strains of live BVDV served as BVDV infected animals; 2 calves were infected with 
BVDV strains NY-1, 1373, and Singer; four calves were infected with strains 28508-5, 
NY-1, and NADL. Colostrum deprived BVD virus- and antibody- negative calves 
raised in isolation were used as control animals. PBMC isolated from the animals 
were incubated with or without live heterologous BVDV (strain 890) in vitro for six 
days. CD3'^, CD4'^, CDS"^, and gamma delta TCR"^ T cells firom the infected animals 
(n=6) increased expression of IL2r when incubated with BVDV, as compared to cells 
incubated without BVDV. T cells from control animals (n=7) did not increase IL2r 
expression when incubated with BVDV. 
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Stimulation of PBMC with bovine herpesvirus 1 
An experiment was designed to determine if a commercially avziilable vaccine 
(Bayer) containing modified-live (MLV) BVDV, bovine herpesvirus 1 (BHVl), 
bovine respiratory syncytial virus, and parainfluenza 3 virus could generate detectable 
T cell subset responses when injected into cattle. Eight calves serologically negative 
for BVDV and BHVl were divided into two groups; five calves were immunized with 
the MLV vaccine, and three calves were separated and received no immunization. 
PBMC were isolated from the animals at weekly intervals and incubated with or 
without live BVDV as described for the previous experiment, and with or without 
heat inactivated BHVl. 
Lymphocytes from vaccinated animals increased expression of IL2r when 
incubated with BVDV, as compared to cells incubated without BVDV. Lymphocytes 
from the BVDV serologically negative control animals also increased IL2r expression 
when incubated with BVDV. Different BVDV serologically negative animals were 
obtained, and their lymphocytes also increased IL2r expression when incubated with 
BVDV. Colostrum deprived BVD virus and antibody negative calves were found to 
use as controls; their T cells did not become activated when incubated with BVDV. 
Altogether, ten different control animals were used, three of which (the colostrum 
deprived calves) proved to be unresponsive to BVDV. While this part of the 
experiment did not yield publishable results and is not reported in this dissertation, it 
lead to some interesting insights into the potential development of antigen specific T 
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lymphocytes in ±e presence of maternal antibody blockade of humoral immune 
response. 
Useable data were obtained regarding BHVl vaccination, CDS"^, 004"^, and 
gamma delta T cells from vaccinated animals increased expression of IL2r when 
incubated with inactivated BHVl, compared to cells incubated without BHVl. CDS"^ 
T cells from vaccinates were not activated when incubated with heat killed BHVl. T 
cells from the ten control animals (all serologically negative for BHVl) did not 
become activated when incubated with BHVl. 
Significance of research results 
The results of the mitogen stimulated activation marker expression 
experiments demonstrated that two-color flow cytometry is a useful method for 
detecting lymphocyte phenotype and activation status. The technique can measure 
differences of activation between lymphocyte subsets and between various stimuli. 
The PKH2 fluorescent cell membrane staining technique is a useful method of 
detecting lymphocyte proliferation. Information regarding proliferation of various 
lymphocyte subsets may be obtained while all the subsets are incubated together and 
allowed to interact, and no radioactive materials are needed. Lymphocyte expression 
of activation markers should not be regarded as being synonymous with proliferation. 
Surface expression of IL2r may be necessary for lymphocytes to proliferate (Miyawaki 
et al., 1982), but another study demonstrated that human lymphocytes may increase 
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IL2r without proliferating (Rubin et al^ 1985) and the results of this research extend 
that finding to bovine lymphocytes. 
The subset proliferation results may clarify the situation regarding which 
lymphocyte subpopulations are proliferating in response to mitogen. When 
incubating complete populations of bovine lymphocytes under conditions similar to 
those in the smdy, blastogenesis results due to Con A stimulation may be due to 
activation of CDS"^, CDS"^, and gamma delta T cells, with a small contribution 
firom B cells. Blastogenesis results from PHA stimulated PBMC may be due to 
activation of CIW, CDS'", and gamma delta T cells. Blastogenesis results 
from PWM stimulated PBMC may be due to activation of CIM"^ and CDS"^ T cells. 
Blastogenesis results from anti-CD3 MAb stimulated PBMC may be due to activation 
of CDS*, CD4*, and CD8* T cells. 
There are few published reports of T cell mediated immune responses of 
cattle to BVDV. Antigen specific blastogenesis (Larsson et al., 1992) and cytotoxicity 
(Beer et al., 1997) have been reported. The manuscript entitled "Antigen specific up-
regulation of Interleukin-2 receptor on T lymphocyte subsets of cattle experimentally 
infected with bovine viral diarrhea virus" is apparently the first report of BVDV 
specific T cell subset activation. Detecting the presence of antigen responsive T cell 
subsets may be an important beginning step toward a better understanding of bovine 
immune responses to BVDV. Combining this information with assays of lymphocyte 
function and subset proliferation may clarify the roles of each T cell subset in 
protective responses to BVDV. 
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This experiment also demonstrated that there is some ability of BVDV specific 
T cells to recognize heterologous strains of BVDV. T cells fi-om most of the infected 
animals became activated when incubated with a strain of BVDV ±at the animals 
had not been challenged with. Flow cytometric detection of antigen specific T cells 
may facilitate the study of T cell immune responses to heterologous, as well as 
homologous, strains of BVDV. The technique may aid the identification of specific 
viral gene products or epitopes recogm'zed by T cell subsets and help to identify 
conserved protective T cell epitopes shared by heterologous strains of BVDV. 
The apparent BVDV specific activation of T cells fi^om BVDV seronegative 
calves was frustrating because it led to data that were not publishable, but may open 
new avenues of research. It has been reported that when calves with colostrum 
derived antibody against BHVl get exposed to the virus, the calves may develop 
BJfVl sensitive memory T cells (Bradshaw et al., 1996; Ellis et al., 1996) or become 
latently infeaed (Lemaire et al., 1995) without generating detectable antibody against 
BHVl. Flow cytometric detection of antigen specific T cell subsets may be a useful 
technique for confirming this observation, and for investigating the possibility of a 
similar phenomenon in calves exposed to BVDV, These observations also raise 
questions about the usefulness of serology to detect prior exposure to BVDV and 
BHVl in catUe. 
The detection of BHVl specific T cell subsets following vaccination 
demonstrates that the two-color flow qtometric assay may be a useful way to 
examine BHVl immune responses and the ability of different types of vaccines and 
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adjuvant combinations to generate CMI responses. While BHVl specific CD4* 
(Tikoo et al., 1995) and cytotoxic cells (Leary et al., 1992; Campos et al., 1992) have 
been described, this is apparently the first report of BHVl responsive gamma delta T 
cells. 
Recommendations for future research 
Cross-strain recognition of BVDV T cell epitopes by T cell subsets 
Chapter four of this dissertation describes evidence that there may be T cell 
epitopes that are conserved between different strains of BVDV. These findings 
should be expanded and more thoroughly investigated. BVDV negative cattle could 
be divided into groups, and each group challenged with a single strain of BVDV. 
Groups challenged with strains of genotype 1 and genotype 2 BVDV should be 
included. PBMC from animals of each group should be incubated in vitro with 
homologous and heterologous virus strains of both genotypes to determine if antigen 
specific T cell subsets generated by challenge with a given strain of BVDV recognize 
antigen from other strains. Similar methods could be used to study the ability of 
modified-live and killed BVDV vaccines to stimulate development of T cell subsets 
that recognize homologous and heterologous strains of virus. 
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Proliferative and functional responses of BVDV or BHVl specific T cell subsets 
The two-color flow cytometric method described in this dissertation can 
identify BVDV or BHVl antigen specific T cell subsets, but the proliferative and 
functional properties of the responsive T cells remain unknown. Proliferative 
responses of BVDV or BHVl specific T cell subsets could be determined by testing 
antigen specific IL2T expression and proliferation (determined by relative PKH2 
fluorescence intensity) in parallel, similar to the experiment described in chapter two 
of this dissertation. For example, PBMC of BVDV infected animals would be 
isolated and divided into two samples. One sample from each animal would be 
incubated in vitro with or without BVDV and analyzed flow cytometrically for 
lymphocyte phenotype and IL2r expression. The other sample of PBMC from each 
animal would be stained with PKH2 prior to incubation with or without BVDV. At 
the end of the incubation period, PKH2 stained cells would be analyzed flow 
cytometrically for lymphocyte phenotype and proliferation. Alternatively, three-color 
flow cytometry of lymphocyte phenotype, IL2r expression, and relative PKH2 
fluorescence intensity could be attempted. 
Effector function of BVDV and BHVl activated T cell subsets should also be 
investigated. Cytokine production by BVDV or BHVl responsive PBMC could be 
determined in a nimiber of ways. PBMC of BVDV infected cattle could be 
incubated with and without BVDV, and the supernatant assayed for a number of 
cytokines by ELISA or bioassay. Cytokine producing cells could be quantitated by 
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ELISPOT. Alternatively, cytokine mRNA of PBMC could be assayed by reverse 
transcription-polymerase chain reaction (RT-PCR) (Kee et al., 1997). 
The phenotype of cytokine producing T cells could be determined by adapting 
previously described methods. PBMC from infected animals would be incubated with 
and without BVDV. After incubation, T cell subsets would be separated using 
immunomagnetic beads (or perhaps by fluorescence activated cell sorting) and T cell 
subset cytokine production detected by ELISPOT (Herr et al., 1996) or RT-PCR. 
Alternatively, PBMC from BVDV infected animals would be incubated in vitro with 
and without BVDV. After incubation, cells could be permeabilized and incubated 
with MAb against various cytokines as well as MAb against T cell subset markers. T 
cell phenotype and intracellular cytokine content would be analyzed flow 
cytometrically (Falchetti et al., 1995). 
Can BVDV antibody negative calves have BVDV reactive T cells? 
While conducting the experiment described in chapter four of this dissertation, 
several BVDV seronegative control animals had T cells that apparently became 
activated by BVDV. The possibility of BVDV antibody negative animals possessing 
BVDV specific memory T lymphocytes should be investigated for three reasons. 
First, as a practical matter, to discover a way to identify truly BVDV negative animals 
for use as control animals in future research. Second, to uncover the mechanism by 
which this might happen. Does the presence of colostral antibody against BVDV 
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inhibit seroconversion of calves without preventing generation of antigen specific T 
lymphocytes, as has been reported to occur with BHVl (Bradshaw et al., 1996; Ellis 
et al,, 1996)? Might these observations be evidence for colostral transfer of antigen 
specific T cell mediated immunity? Thirdly, the diagnostic and epidemiological 
implications of such a phenomenon may be important. 
Neonatal calves could be given experimental colostrum. One group of calves 
would receive colostrum known to be free of BVDV or BVDV antibody. Another 
group of calves would receive colostrum containing known concentrations of BVDV 
antibody. Calves sera would be tested for presence of BVDV antibody. Calves 
would then be challenged with live BVDV. Serum antibody titers would be tested, 
and PBMC would be tested at regular intervals for the presence of BVDV specific T 
cells. A similar experiment could be done using BHVl in order to corroborate 
previous reports. It would be possible to determine if live or killed vaccines differ in 
their efficiency of inducing different memory T cell subsets in the face of maternal 
antibody. 
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